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A STUDY OF EARLY SYPHILIS. ITS TREATMENT
AND TITS MANAGEMENT OP THE REACTIONS TO TREATMENT.
INTRODUCTION.
Syphilis has heen recognised for at least four centuries. 
During this time it has received much attention and study and 
its protean manifestations including the late effects in the 
central nervous system, have come to he recognised.
Early accounts of the disease reveal its epidemic occurrence 
and malignant nature. The great syphilologists of the 19th 
century including Ricord (l), Fournier (2) and Hutchinson (3) 
also mention manifestations of greater severity than those 
encountered in cases of syphilis seen during the last decade.
It appears therefore that the virulence of the infection has 
become attenuated over the intervening years or that racial 
immunity to the infection has increased. For the purposes of 
comparison it is, therefore, of val ue to record the findings of 
a diudy of primary and secondary syphilis as encountered at the 
present day. Venereal disease is truly a camp—follower of war 
and the opportunities for a clinical study of syphilis in the 
British Army during the recent world war have heen unique.
The policy adopted in the British Army laid down that all 
cases of venereal disease must he admitted to the appropriate 
section of a military hospital and retained there until non- 
infectious. Amongst other advantages., this policy provided 
ideal conditions for the detailed study of the early manifest­
ations'of syphilis.
As these patients are subject to military discipline,
^heir treatment and subsequent observation, v/ere more complete 
than would have been possible in civilian practice. It was 
considered that a study and permanent record of such cases, 
infected in the United Kingdom, would be of value and that 
useful guides to treatment could be obtained by studying the 
results of the serological reaction of the blood in relation to 
treatment with various schedules of trivalent arsenical compounds 
and with penicillin. Furthermore, because patients who had 
severe reactions to treatment could be admitted to hospital I 
enjoyed unusual opportunities for the study of such complications 
and of investigating new methods of their treatment.
The resulting study falls into three sections 
Section 1.
A detailed clinical study and analysis of the signs 
and symptoms of 250 cases of primary and secondary 
syphilis.
Section 2. j
A study of the reversal of the serological reaction 
of the blood in relation to treatmeiit with various '
treatment schedules.
Section 5.
A study of major reactions to trivalent arsenical j
confounds with special reference to new methods adopted 
in their management.
(3)
A DESCRIPTION OF THE PRESENT STUDY.
MATERIAL.
The clinical material considered in the first section of 
this study was confined to British personnel in His Majesty’s 
Forces infected in the United Kingdom. All cases were admitted 
to wards under my care for a minimum period of twelve days, 
the average heing nineteen days.
The case reports, diagnosis and treatment were carried out 
personally, as were all laboratory procedures with the exception 
of the serological reactions.
250 cases of primary and secondary syphilis were studied 
and a complete analysis is presented in Section 1.
The material considered in Section II is composed of the 
records of 979 patients. It was confined to patients treated 
in my wards and out-patient department over a period of two years 
in the United Kingdom and six months in the Central Mediterranean 
Forces.
All the material relating to treatment with the trivalent 
arsenical compounds was taken from the records of my out-patient 
department in the United Kingdom where the number of injections 
of the arsenical compounds was 8,000 per year. The study 
consists of 819 cases. The material relating to treatment 
with penicillin was studied in my out-patient department in the 
Central Mediterranean Forces and relates to 160 cases.
The ca.ses considered in Section III were studiedin my wards 
and out-patient department in the United Kingdom.
(4)
METHODS USED IN CASE TAKING, EXAMINATION AND 
LABORATORY PROCEDURES.
For the purposes of the first section of this study a 
special case record was prepared, the form of which was as follass
EARLY SYPHILIS.
Gase Ho.
Name. No. Rank. Unit.
Age. Service. Date of Admission. Married/Single.
Concomitant diseases.
General Examination.
Cardio-vascular system 
Respiratory system 
Genito-urinary system 
Alimentary system 
Nervous system 
Date of infection. Date when first lesion noticed.
Lesion first noticed. LoeaL treatment.
Circumcised/uncircumcised.
Is the chancre typical. Yes/No
(1) Number
(2) Size
(3) Shape
(4) Position
(5) Base
(6) Edge
(7) Haemorrhagic line
(8) Haemorrhagic hand
(9) Oedema
10) Induration
11) Discomfort
12) History of trauma
Date enlarged glands first noticed.
(5)
Glands: Inguinal. Axillary. Cervical. Eni trochlear.
R. L. R. L. R. L. R. L.
No.
Size.
Shape.
Consistence.
Date rash first noticed.
Description of rash and distribution.
Date raucous lesions noticed.
Description of lesions and distribution.
Symptoms of secondary syphilis.
Date of dark-ground examination of serum. Lesion. Result. 
Date of gland puncture if performed. Group of glands. Result. 
Details of Jarish-Herxheiraer reaction.
Other reactions to treatment.
On admission to hospital the patient was examined stripped 
in a well lit theatre and the clinical details recorded on the 
case-sheet. The clinical examination was followed by dark- 
field examination of serum from a primary or secondary lesion, 
or if neither of these were available, by gland puncture in 
suitable cases. Following this,10cc. of venous blood were 
taken for serological examination.
The pa tient was then interviewed privately and the nature 
of his infection explained to him. The history was tnen taken*
(6)
It was found that by discussing the patient’s problems 
sympathetically with him and gaining his confidence, a more 
accurate and detailed history could be obtained, justifying the 
time expended.
The exact date of the first appearance of some lesions could 
not be accurately obtained in some cases in relation to the time 
of infection and, in other cases, repeated exposures to infection 
obscured the date of infection. Msay cases, therefore, had to 
be excluded from the statistical analysis in this study.
Dark-field Examination of Serum from Primary and Secondary Lesions 
The technique used in dark-field examination of serum was 
as follows
(a) The patient was informed that the procedure was not 
without pain but was a necessary one and he was urged not 
to move.
(b) The lesion was thoroughly cleaned and rubbed with gauze 
soaked in normal saline.
(c) A piece of cotton-wool damped with surgical spirit was 
applied to the lesion for five seconds.
(d) The lesion was then dried with cotton-wool and gently 
compressed.
(e) The exuding serum was picked up in a fine glass capillary 
tube from the edge of the lesion and transferred to the 
microscope slide by sealing the distal end of the tube in a 
Bunsen flame and forcing the serum out on to the slide.
(f) A cover-slip was applied over the serum and a minimum of 
fifteen minutes was spent in searching the slide for Treponeme
(7)
pallidum. If no T. pallida were seen the lesion was 
dressed with gauze soaked in normal saline and the procedure 
repeated on two successive days.
Gland-nunc tur es.
In gland-punetures the "wet’1 method was used. O.lcc. of 
sterile normal saline was injected into the gland from a l.Occ. 
syringe, the needle rotated, the gland knee&ed and the aspirated 
fluid examined. The result of the dark-field examination was 
recorded as one, two, three or four plusses.
++++ represented an average of more than two T. pallida 
per field.
+++ represented an average of one T. pallidum per field.
-M- represented one T. pallidum to less than twenty fields.
+ represented less than one T. pallidum to every twenty 
fields.
Serological Reactions.
The serological reactions were confined to Wasserman11 and 
Kahn tests. The tests were not carried out personally, hut 
were carried out at the same laboratory except for the Kahn 
tests recorded after treatment with penicillin. Wassermann 
Reactions were carried out according to the Medical Research 
Council Method I. (14). In the Kahn Tests the method was one 
using two tubes contal ning anti gen- serum, mixtures of 1 in 12 and 
1 in 6.
Other Laboratory Procedures.
Blood counts were carried out personally, as were
(8)
estimations of serum bilirubin. The method of determining 
the serum "bilirubin was a colorimetric one using Gibson and 
Goodrichs1 modification of Van den Bergfs method. (56)
Prom considerations of space and for the sake of brevity, 
the case records which have been included in the third section 
are presented briefly. Negative findings unless considered 
important have not been included.
Photography.
Thephotographs included in Section I are taken from the 
material analysed and have been included to give completeness 
to the description and analysis of the cases.
(9)
B E O T  I O K I.
(10)
SECTION I.
A CLINICAL STUDY AND ANALYSIS OF THE SIGHS AND SYMPTOMS 
OF PRIMARY AND "SECONDARY SYPHILIS IN A SERIES OP 250 CASES.
PRIMARY SYPHILIS.
Dark-field examination of serum from open lesions usually 
provides rapid and accurate diagnosis of primary syphilis; 
clinical criteria alone can never he considered adequate.
The patient with the atypical primary lesion is no longer kept 
in suspense until the secondary stage of the disease develops.
A certain diagnosis can he made and treatment started within houn 
of the first appearance of the chancre.
It is considered that the so-called “typical11 chancre is 
not as common in present day practice as one is led to helieve 
hy many text hooks.
During the present study pyogenic infections including 
infections with the bacillus of Ducrey, have heen seen which 
aped the Hunterian chancre and have heen proved to he non- 
syphilitic hy repeatedly negative dark-fieid examinations and 
serological reactions.
In 1939 and 1940 Unit Medical Officer?s* "index of 
suspicion" with regard to syphilis was extremely low due to the 
rarity of early syphilitic infections in peace time. As the 
snow-ball of venereaL disease in this country gained size and 
momentum and as Medical Officers were required to give health 
lectures and examine troops for venereal disease the "index of 
suspicion" rose rapidly.
(ai)
Among admissions to hospital in this series of 250 cases 
of syphilis were 67 non-syphilitic cases sent up with a 
tentative diagnosis of primary syphilis. This amounted to 27% 
of the total. Excluded from this number were cases of obvious 
scabies, usually with penile burrows. In these cases one 
dark-field examination of serum was carried out, blood was taken 
for a Kahn test and the patient was returned to his unit on the 
same day with instructions to report monthly for the next three 
months for a Kahn test.
The diagnosis in the 67 cases was as follows:-
Chancroid ... ... 15
Erosive balanitis ... 12
Pyogenic infections
(probably post-traumatic) 12
Infected scabetic lesions 10
Traumatic lesions ... 7
Herpes genitalis ... 6
Infected Tyson* s gland ... 1
Epithelioma ...
Ulcers after removal of 
Condylomata acuminata
Infected sebaceous cyst 
Cutaneous diphtheria 
It is considered that this 27% indicates a fairly high "index 
of suspicion11.
1
1
1
(12)
Chancroid simulating a primary chancre.
Scahetic burrows in the skin of 
the penis.
^ost-scabetic abscess of 
the penis.
(15)
In all cases of primary syphilis before any laboratory 
diagnosis was attempted a note was made as to whether the 
chancre was typical or atypical. In this series only 64% of 
the cases were considered to be typical text-book chancres.
This figure reflects the fact that many of the primary lesions 
were seen at an early age and had not developed induration or 
oedema, but also points to the great fallability of relying 
solely on clinical criteria for the diagnosis.
Incubation Period.
In 310 cases it was possible to determine the exact 
incubation periods. The average incubation period was 28.4 
days. The shortest incubation period, occurring in two cases, 
was ten days and one case had the exceptional incubation period 
of 92 days. A tabulated comparison from various autliorities is 
given below.
Average Incubation Shortest Longest
Lees (6) 15-21 days 10 days 70 days
Burke (7) 30 days 10 days 84 days
Kampmeier (8) 10-20 days 8-10 days 90 d^rs
Marshall (9) 25-28 days 10 days 70 days
Harrison (10) 28 days -
Present series 28.4 days 10 days 92 days
The Site of the Chancre.
Primary chancres Occurred in order of frequency on the 
following sites.
(14)
Mucous membrane of prepuce 
Coronal sulcus of glans penis 
Clans penis 
Frenura
Shaft of penis 
Edge of prepuce 
Para-frenal 
Skin of prepuce 
Urinary meatus 
Extra-geni tal 
Scrotum 
Pubic area
Characteristics of the Primary Chancre
17%
12%
n %
n %
9%
6%
1%
The typical or Hunterian chancre is usually described as a 
solitary, painless, round or oval ulcer with a depressed eroded 
surface of a raw ham colour. It has a raised edge with a thin 
haemorrhagic line and a firm "button lik$ indurated base.
The various characteristics found in my cases have been 
analysed,
Number.
Although most text books state that chancres are usually
single, 45.4% of cases had multiple chancres. It was thought
that multiple chancres might occur more frequently in the
uncircuracised. As seen from the following statistics the
difference is less than 1%. This negligible difference is
accounted for by the "kissing" type of chancre in the 
uncircumcised.
(15)
Chancres in the circumcised:
Single
Multiple
55%
45%
Chancres in the uncircumcised
Single
Multiple
54.2%
45.8%
A factor which may he responsible for multiple chancres 
rather than solitary ones is the presence of mucous lesions in 
the consort as it has been shown by Morgan (57) that inoculations 
with one to six spirochaetes in the rabbit do not cause infection 
It can reasonably be deduced that more positive inoculations 
will take place when the consort has mucous lesions.
All the extra-genital chancres in this group were confined 
to the lips, one being on the upper lip and the remainder on the 
lower lip.
Size and Shane.
The chancres varied in size from that of a pin-head to one 
covering half the side of the shaft of the penis and measuring 
Zi inches by lj inches. The average size was about i inch by 
i inch.
74% of the chancres were approximately round and the reraaindea 
were roughly oval in shape.
Pain and Discomfort due to the Chancre.
8.2% of the cases complained of pain and 62% complained only 
of discomfort. The usual complaint was one of slight discomfort 
often associated with rubbing of the sore against under-clothes
(IS)
Extra-genitaL chancres of the lips
(17)
or 'battle-dress trousers. Four cases complained of definite 
pain and in all these cases there was another, more obvious 
reason than the specific infection for this symptom. Two 
cases had phagedenic chancres, the third was a mixed infection 
of chancroid and syphilis and the fourth was a very large 
chancre of the shaft of the penis with marked secondary infection 
The Base of the Chancre.
Unfortunately, in this series of cases, no chancre was seen 
at an early enough stage to be described as a raised papule with 
a smooth surface. All the lesions studied had some erosion of 
the surface. In 41% the base could be described as the colour 
of raw ham but in the remainder the base was a greyish-yellow 
colour with gross secondary infection.
The level of the Base of the Chancre.
No real edge could be noted in 5% of the chancres, the base 
being on the same level as the surrounding integument. These 
cases were all seen within the first few days of the appearance 
of the chancre. In no case was the base elevated above the 
surrounding skin or mucous membrane.
The Edge of the Chancre.
The edge of the chancre has been described by various 
writers as "Flat, not elevated or rolled" (5), "Slopes gently" 0^ ) 
"Sharp regular edge" (9), "Raised" (6), "Border smooth with no 
undemining" (7) and "Even and rolled" (8). This diversity of 
description reflects on the diversity of appearance rather than
on the acumen of the observers.
In the unhealed chancres observed, the edge could be
(18)
Multiple chancres.
<19) '
described as rolled in 58%. punched out but not undermined in 
23.%, end shelving in 16% of cases. 5% had no clear cut edge, 
either elevated or depressed.
It is apparent that three factors:
(a) The age of the sore,
(*) The presence or absence of induration and oedema, I
(c) The presence or absence of secondary infection, 
are responsible for the type of edge seen in the primary chancre. 
The Areola Surrounding the Chancre.
In 54% of cases a haemorrhagic line was noted running round 
the edge of the chancre. Only in 20% of cases did this line 
remain unbroken and surround the ulcer completely.
Harrison (10) states that in a chancre the areola is a band, 
while in chancroid it is a thin line. This could not be 
confirmed in this series of cases. Some cases could be 
described as a band and some as a line. Many exhibited both. 
Induration and Oedema Around the Chancre.
Induration and oedema were found to be present in 80% and 
77% of the cases respectively.
It was noted that these signs tended to be minimal when the 
chancres were situated on the glans penis and that absence of 
induration occurred in the early chancres and absence of oedema 
in the early and late chancres.
The findings in primary chancres are summarised below.
Multiple chancres of the pubic area.
Multiple chancres on the glans and coronal sulcus
(21)
Number, Single ... 54.6%
Multiple ... 45.4$
Size end Shape ... \ in. hy ^ in.
Round ... 74%
Oval 26%
Pain • • • • • • 8.2%
Discomfort • • • • • • 62%
Surface. Plat . ... 5%
Depressed . •. 95%
Base, Raw ham 41%
Greyish-yellow 59%
Edge, Rolled 58%
Punched out.. 21%
Shelving ... 16%
No edge 5%
Areola, Present 54%
Absent . . • 46%
Induration, Present ...
o00
Absent ... 20%
Oedema, Present ... 77%
Absent 23%
Adenitis Associated with the Chancre.
In a purely syphilitic genital chancre the associated 
inguinal adenitis has heen described as "shotty" or "india 
rubber like11.
It was observed that without secondary infection, glands 
smaller than a bean felt shotty and the glands had to be of
(22)
“French letter*1 chancre of scrotum,
Hour-glass chancre.
greater size than a bean before the typical india-rubber like 
consistency could be detected.
The occurrence of enlarged inguinal glaids in relation to 
the date of infection was as follows
Week of infection. Presence and size of glands.
1st week Nil
2nd week Nil or small (less than size of bean)
3rd week small
4th week Large, (greater than size of bean)
5th to 10th week Large becoming generalised.
In twenty-four cases of genitaL chancre no enlargement of 
the inguinal glands was present. All these cases were seen 
before the fourth week of infection.
No case of bubo was encountered with a pure syphilitic 
infection and the india-rubber consistency of enlarged inguinal 
glands was usually present after the fifth week of infection.
The site of the chancre did not always influence the side on whid 
the inguinal glands first enlarged. A chancre on the right side 
of the penis might be accompanied by enlargement of the right 
inguinal glands al one, or the left inguinal glands or both. 
Dark-field Examination of Serum from Qhancres.
As already described, the results of the dark-field 
examination of serum from chancres was recorded by the following 
system.
++++ represented an average of more than two T. pallida per field.
+++ represented an average of one T. pallidum per field.
20
++ represented an average of one T. pallidum pe^/fieldS.
+ represented an average of less than one T. pallidum to
every twenty fields.
These groups were further sub-divided according to the 
number of the dark-ground examinations carried out before a 
positive result was obtained. Serum from the chancres was 
examined on three successive days unless a positive result was 
obtained at the first or second examination.
The results were as follows :-
GPQU£i«*3i* 4—t*4"4* +4*+ 4*+ +
1st Examination: 10 17 97 29
Group II.
2nd Examination: Nil Nil 6 Nil
Group III.
3rd Examination: Nil Nil 1 Nil
A positive result could not be obtained in 6% of cases. 
This constituted eleven cases.
5 cases: Chancres practically healed.
1 case: Chancre of lip with much secondary infection.
2 cases: Genital chancres having had local treatment.
Gland punctures v/ere positive.
3 cases: Genital chancres having had no local treatment.
Gland punctures were positive in two of these 
cases.
It is considered that 94$ of positive results in all cases 
is satisfactory and that in unhealed lesions ^Lower percentage 
of positive results is due to poor technique.
In this group of cases 28% had had some local treatment. 
While this did not materially affect the demonstration of
(25)
Treponema pallidum it was found that the results of 
examination from these cases fell into the ++ and + groups.
SEROLOGICAL REACTIONS IN RELATION TO:
(a) THE DURATION OF THE CHANCRE.
(h) THE DURATION OF INFECTION.
(a) Stokes (5) states that the Wassermann Reaction in cases 
where the chancre has "been present-for just over a week is ' 
positive in from 35% to 50% and climbs to Q0% or more at the 
end of the 8th week. It is considered that this results from 
a relatively insensitive Wassermann Reaction. He gives the 
following table of methods and results.
Date of Appearance of Positive Serological Tests in
Primary Syphilis.
Method Per cent. Positive Total Number 
of cases
1 wk. 2 wks. 3 wks. 4 v/ks. 5 wks. 6 wks
Oraig 
(W.R.)
36.5 59.3 69.9 77.2 81.3 600
Kolmer 
(W.R.)
4 4 - 7 5 82 94
Irving 
(Kolmer) 
Stem 
(W.R. )
66.6 80 8
wilier1 ■
Nagle
(Kahn)
56.2 89.8 90.5 88.9 100 105
Klauder 36 64.7 70+ 100
(26)
Burke (7) gives the following figures
Week of Chancre. Percentage Positive
Wassermann Reactions.
1 25
2 50
5 66
4 80
5 90
The Wassermann Reactions in the cases investigated were 
as follows
Week of Chancre. Percentage Positive
Wassermann Reactions.
a 40
3 44
6 59
5 100
Cb) A grgph showing the percentage of positive results in 
relation to the duration of infection is appended.
(27)
S i ITOBflriOEf
(28)
THE MANIFEST ATI QNS OP SECONDARY SYPHILIS,
Seventy five eases of secondary syphilis are included in 
this study and the manifestations are considered under the 
following headings
1. Cutaneous rashes.
2. Mucous lesions in the mouth.
3. Condylomata lata and moist papules.
4. Generalised Adenopathy.
5. Other manifestations of secondary syphilis.
6. The symptomatology of secondary syphilis.
X. CUTANEOUS RASHES.
Cutaneous rashes due to syphilis were present in sixty three 
cases. In twenty one of these, more than one third of the 
total number, the rash was polymorphic.
The type of rash, the number occurring in this series and 
the average incubation period from the time of infection are 
tabulated below: -
Average incubation -periodTyne of rash No., of 
Cases.
Macular syphilide 44
Papular syphilide 33
Pustular syphilide 5
Ecthymatous syphilide 2
in weeks. 
11.2 
15.0 
24.5 
26.3
syphilides occur much later in the infection than the macular
( 2 9 )
Maeulo-papular syphilide
Plantar Papular syphilide
(30)
and papular syphilides.
The Macular Syphilide,
The average incubation period of macular syphilides 
calculating from the date of infection to the appearance of 
the rash was 11.2 weeks. As the average incubation period for 
all primary chancres in this series was 28.4 days the macular 
rashes appeared about 7 weeks after the primary lesion. This 
is in agreement with most authorities.
The distribution of this type of syphilide was found to be 
symmetrical and principally on the flexor surfaces of the arms, 
the sides of the neck, flanks, back and chest. The face, 
except for a few macules on the chin in five cases, was not 
affected and the lesions were usually scanty on the legs. The 
paLms and soles were not affected.
The macules varied in size from about ith of an inch to 
half an inch and were round or oval in shape. The colour 
varied from a light to rose pink.
Nearly all the macular syphilides seen in this series 
exhibited a Jarish-Herxheimer reaction after the first intra­
venous injection of arsenic. No pigmentary syphilides of a 
macular type occurred in this group.
Papular Syphilides.
The papular syphilides have been divided up into the 
follom ng sub-groups:-
(31)
Papulo-pustular syphilide
Maculo-papular 
Papular
Psoriasiform-papular 
Follicular 
Annular-papular 
A comparative table of the frequency of occurrence and 
incubation periods has been compiled,
Tyne No, Incubation period
in weeks.
Maculo-papular 19 14.5
Papul ar 7 15.2
Psoriasiform-papular 5 18.5
Follicular 1 Not known
Annular-papular 1 More than twenty
Maculo-papular Syphilides.
In cases where more than one type of rash co-existed the 
commonest combination was a macular and a papular rash.
The average incubation period of the maculo-papular rashes 
was three weeks longer than that of the pure macular rash, 
showing that while the papular types occur relatively early in 
the infection they are usually a later manifestation than the 
macular types.
In the maculo-papular type the distribution was similar 
to that of the macular syphilide except that the palms and soles 
were often involved, as was the face, especiaL ly at the hair 
line.
The papules were round and slightly elevated above the
(33)
(54)
surrounding epidermis. They were of a rose-pink colour and 
varied in size from ^ to f- of an inch in diameter. In many 
cases the induration of the papules could he felt.
The Papular Syphilides.
Seven cases with a papular syphilide were observed. The 
average incubation period was 15.2 weeks.
This type of lesion was invariably found on the flexor 
surfaces of the limbs and trunk. In two cases the lower half 
of the face was affected and in one case the forehead. The 
palms of the hands were involved in one case and the soles of 
the feet in another.
The papules varied in size from a pin-head to nearly half 
an inch in diameter. They were of a dusky pink to copper tint, 
flat topped and discrete. All the papules were indurated.
One case v/as of the squamous type with scaling at the edge 
and some necrosis of the centres of the papules.
Psoriasiform-papular Syphilides.
Five cases of secondary syphilis exhibited papular rashes 
of the psoriasiform type and their average incubation period 
from the time of infection was 18.5 weeks.
In four of these cases, the distribution was the flexor 
surfaces of the limbs, the chest and the back. In the fifth 
case the palms and soles were also affected.
The psoriasiform lesions tended to be larger than any 
other type of papular syphilide. Some were more than one inch
(35)
-
Psoriasiform and Papulo-sqnaiaons 
s;yp>hilide with necrosis.
(36)
in diameter. The papules were of a distinct dusky copper hue, 
darker in colour than the pure papular rash. The scales were 
thin and easily removed. It was noted that in the 
psoriasiform-papular syphilides induration was marked.
Follicular Syphilides.
One case with a follicular rash was studied. In this case 
it was xmfortunately impossible to obtain an accurate history as 
to the first appearance of the rash, the patient being rather 
dull mentaL ly. The distribution was symmetrical and confined tc 
the flexor surfaces of the arms, the chest and back. The scalp 
was not involved. The lesions were pin-head in size, brown in 
colour and conical in shape. The patient complained that the 
rash was accompanied by a slight itching.
Annular Syphilides.
One case in this group had an annular syphilide. The 
incubation period could not be accurately ascertained but it was 
at least of twenty weeks duration.
The lesions occurred on the fore-arms and thighs, on the 
flexor surfaces and were both circular and polycyclic. The 
colour was a copper-red and the edges were raised. The centres 
were less intensely pigmented than the periphery and the lesions 
were indurated.
Pustular Syphilides.
Five cases of pustular syphilide were seen in this series.
Only one was almost purely pustular, the remaining four being 
Papulo-pustular. mhe average incubation period was 24.5 weeks.
(37)
Papulo-pustular syphilides
(38)
The distribution of pustular syphilides was symmetrical and 
confined to the flexor surfaces of the limbs, the trunk and 
scalp* The face was least affected and the hacks of the hands 
were not involved. In four of the five cases lesions were fourr 
in the scalp. In three cases the palms and soles were involved 
and in one case the palms only.
The individual lesions were discrete and dark red in colour 
with a crusted top. When the crust was removed a small ulcer 
was seen. The crusts varied in size from ahout ■§■ to § of an 
inch and there was very marked induration.
Ecthvmatous Syphilides.
Two cases of rupial syphilides occurred in this series.
The average incubation period was 26.3 weeks which is not in 
accord with Harrison1s (10) statement that this type of 
eruption usually occurs ahout two years after the infection.
The distribution in these cases was the scalp, face, upper arm, 
shoulders, hack and chest.
The lesions were oval or circular in outline, discrete and 
indurated. They were covered with a conical, dark brown thick 
crust. After removal of the crust a punched out, indurated 
ulcer remained. The size varied from i to !•§• inches in 
diameter. After some weeks of treatment these lesions healed 
leaving a slightly depressed, thin, pigmented scar.
(39)
Papulo-ecthymatous syphilide
Rupial syphilide.
(40)
• MUCOUS LESIONS IN THE MOUTH.
Mucous lesions in the mouth were studie^in 44 patients.
The distribution ana frequency of occurrence of these lesions 
is shown in the following table:-
Pi,s/fcr ibu t i on. Frequency of Occurrence.
Tonsils ... ... 13 cases
Buccal mucosa ... ... 14 cases
Anterior pillar of the fauces 12 cases
Soft palate ... ... 3 cases
Tongue ... ... 3 cases
Floor of the mouth ... 2 cases
Uvula ... ... 1 case
Gums ... ... 1 case
The average incubation period of these mucous lesions was 
12.2 weeks. They occurred most frequently on the tonsils as a 
milky-white patch with an irregular outline, or if the surface 
had been eroded, as a shiny granulating erosion. Occasionally 
ulceration was present with sane destruction of tonsillar 
tissue and in these cases the base had a dirty sloughy appear­
ance. When the tonsils were the site of a mucous lesion, it 
was not uncommon to find hyperaemia of the free border of the 
soft palate and of the uvula.
Lesions of the buccal mucosa were seen in fourteen patients. 
The lesions were round or oval in shape. If not eroded 
they appeared as silvery-grey plaques, slightly raised above
(41)
Eroded raucous patch on the tongue
Mucous lesions of the soft palate.
the surrounding mucosa and surrounded by a red areola. If
the lesions were eroded they presented a flat, shiny, 
granulating surface, usuaLly without so marked an areola. The 
lesions occasionally coalesced. No induration was present and 
the most common site was just posterior to the angles of the 
mouth at the level of the b^ite** where the "buccal mucosa is 
subject to the greatest amount of friction. The second 
commonest site was on the buccal surface of the lips, 
especiaLly the lower lip.
Mucous lesions seen on the anterior pillar of the fauces 
were similar to those seen on the buccal mucous membrane unless 
ulceration was present. They were often associated with 
secondary lesions of the tonsils. When ulceration was present 
the base had a grey sloughy appearance and the edge a darker hue 
than the surrounding mucosa. The typical snail-track ulcer 
was present in four cases.
Mucous lesions of the soft palate and uvuia were similar to 
those described on the buccal mucous membrane.
Three mucous lesions of the tongue were seen. All of 
these were more or less centrally placed. Two were situated 
at the junction of the anterior third and posterior two thirds 
of the tongue and the third lesion was situated more posteriorly. 
They appeared as a roughly circular, bald, red and atrophic 
patch. This appeared to be devoid of the normal papillae of 
the tongue. No hypertrophic lesions were seen on the tongue.
Lesions on the floor of the mouth occurred in two cases. 
They were situated anteriorly and were small oval red erosions 
which lacked the sheen of the surrounding mucous membrane. in
(45)
Mucous lesions of the lower lip
(44)
one case an areola of a darker pink surrounded the erosion.
Mucous lesions were observed on the gums in one case. They 
appeared on the inter-dental papillae and spread round the denta] 
margin of the gum* These lesions had the typical milky- white 
appearance hut were not surrounded by a definite areola.
All mucous lesions of the mouth occurred,011 an average, 
eight weeks after the appearance of the chancre and were 
characterised by a silvery-grey appearance, unless eroded, 
when they had a flat red granulating surface. No induration 
was present and with treatment all healed rapidly without 
pigmentation.
I
(45)
Peri-anal condylomata lata.
(46)
III. G(HDYLOMATA LATA AND MOIST PAPULES.
Condylomata lata occurred in 23 cases. The distribution 
and frequency of occurrence are given below. The average 
incubation period was 22.3 weeks after the appearance of the 
chancre.
Distribution. Frequency of Occurrence.
Peri-anal region and scrotum 16 cases
Scrotum • • • • • • 7 cases
Shaft of penis • • • • * • 2 cases
Thighs • • • ♦ • • 2 cases
Umbilicus • • • • • • 2 cases
Axillae • • • • • • 2 cases
Between the toes • • • • • • 1 case
Gondylomata lata were found most frequently in the peri-anal 
region and at the apposition of the buttocks. The colour 
varied from a silvery-pink to a dusky red colour and the lesions 
were flat topped and not pedunculated. Occasionally there was 
undermining of the edge due to the rai sed and hypertrophic 
nature of the lesions. The size varied from a few millimetres 
to ten centimetres when the lesions coalesced. The base was 
indurated and when condylomata were present in a patient with a 
low standard of personal hygiene they were covered with a 
purulent exudate and accompanied by a typical odour.
The muco-cutaneous junction at the anus and about i inch
of the surrounding skin was commonly devoid of condylomata lata,
(47)
Peri-anal condylomata lata
Condylomata lata of Umbilicus.
(48)
Moist papules, however, were seen in this area.
Condylomata lata on the scrotum occurred most frequently on 
its posterior surface and could hest "be demonstrated "by putting 
the scrotal shin **on the stretch11. These lesions were smaller 
and less elevated than those found “between the “buttocks and were 
of a dusky red colour with occasional scaling of the top of the 
lesion.
When condylomata were observed on the shaft of the penis 
they were similar to the scrotal lesions. In one case, when 
seen on the thighs they were similar to the scrotal lesions 
“but in the other case they were frambesiform and of a dusky 
“blueish-red colour.
When observed in the axillae, umbilicus and between the toes 
they were greyish-pink in colour, elevated and flat topped.
Bark-ground examination of serum obtained from condylomata 
lata was invariably found to contain many T. pallida.
Moist papules were found with the following distribution 
and frequency:-
Scrotum
Distribution. Frequency of Occurrence 
10 cases
Shaft of penis ...
G-lans penis and mucous 
membrane of prepuce
8 cases
7 cases
Peri-anal region 7 cases
Thighs 1 case
The average incubation period of these lesions was 16.8
(49)
Condylomata lata of axillae.
,
Uondylomata lata or scrotum.
weeks after the appearance of the chancre.
Moist papules most commonly appeared on the posterior 
aspects of the scrotum as pink shallow ulcers with a straight or 
shelving edge. Occasionally they were hypertrophic and had a 
base "built up above the surrounding dermis. If much secondaiy 
infection was present the "base "became grey and sloughy in 
appearance.
The average incubation period for these lesions was 
16.8 weeks.
Moist papules on the shaft of the penis were seen most 
commonly on the ventral aspect of the proximal third and at the 
peno-scrotal angle where the penis and scrotum are normally in 
apposition. The lesions were oval or circular in outline and 
varied in size from i inch to lj inches in diameter.
The moist lesions seen on the glans penis, in the coronal 
sulcus and on the mucous membrane of the prepuce were pink in 
colour with a flat, eroded surface. Those seen around the 
anus varied in size from i inch to i inch and occurred in the folds 
of the mucosa. In two cases they were superimposed on external
haemorrhoids. The papules were dark red in colour and had
an eroded surface.
One case exhibited moist papules on the thighs which were 
similar to those observed on the scrotum. They were confined 
to the inner aspects of the upper thirds of the thighs.
Induration was present in all these lesions and the serum 
obtained from them contained many T. pallida.
(Bi)
Moist papules and condylomata lata*
Moist pspules of penis and scrotum.
(52)
IV. GENERALISED ADENOPATHT.
The regional adenopathy in relation to the primary chancre 
has already "been described.
On examination of a patient with secondary syphilis it was 
usual to find that even in the presence of a healed penile lesion 
the inguinal glands were larger than the other superficial lymph 
glands in the body. This was a universal finding when the penile 
lesion was unhealed.
The superficial lymph glands in the neck, in both the 
anterior and posterior triangles, were commonly enlarged as were 
the glands in the femoral region. It was found more often than 
not that these glands had a shotty consistence rather than an 
india-rubber feel. This was directly related to the size of 
the glands which were about the size of a bean or less.
The epitrochlear glands were sometimes enlarged but as ofter 
as not only one was palpable. They were of. the shotty variety 
and none enlarged sufficiently to have an india-rubber feel.
Most soldiers have palpable axillary glands whether they 
are suffering from syphilis or not. In a group of 200 cases 
suffering from diseases other than syphilis, 94$ had palpable 
axillary glands varying in consistency from shotty to soft.
It is considered that the frequent inoculations and vaccinations 
carried out in the army are responsible for this finding.
A graph is appended illustrating the change found in the 
superficial lymph glands of the body as the syphilitic infection
progresses.
(53)
It is shown "by the graph how the generalised enlargement of 
the lymphatic glands occurs about the 10th week of infection.
In two cases where a generalised enlargement of the superficial 
lymph nodes waspresent but who presented no other clinical 
signs of secondaiy syphilis, a maculo-roseolar rash of a 
transient nature was seen after the first injection of 
neoarsphenamine.
(54)
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V. OTHER MANIFESTATIONS 0? SECOHPART SYPHILIS.
In four cases enlargement of the epididymis was present*
(
This was unilateral in three cases and "bilateral in one case. 
The incubation period varied from 12 to 52 weeks, the average 
incubation period from the date of infection "being 24 weeks.
The epididymis v/as found to be enlarged and smooth and the 
swelling completely subsided after a few injections of neo- 
arsphenamine.
No enlargement of the liver or spleen attributable to 
syphilis was observed nor was there a case of syphilitic 
nephritis in this series.
One case of syphilitic iritis occurred in the 18th week of 
infection. The condition cleared up quickly with atropine eye 
drops and routine anti-syphilitic treatment.
(56)
VI. THE SYMPTOMATOLOGY OF SECONDARY SYPHILIS.
The symptomatology of 75 patients suffering from secondary 
syphilis is given helov/. Only 25 patients, one third of the 
total number, complained of any symptoms attributable to the 
syphilitic infection.
Sore throat (including Hoarseness) 15
Headache ... • • • 9
Malaise ... • • • 9
Loss of weight ... • • • 6
Feverishness • • * 4
Myalgia • • • 2
Bone pains • • • 1
G-astro-intestinal • • • mi
Deafness ... • • • Nil
Insomnia .. • • • • Nil
In no instance of primary syphilis could a definite history 
of constitutional symptoms he elieitated. A few patients 
with primary syphilis gave a history of headache in answer to 
a leading question. None complained of this symptom 
spontaneously and on further questioning the headaches bore no 
relation to the time of infection but had been occurring prior 
to infection. Stokes (5) quotes Fournier as estimating that 
50% of vomen and 75% of men experience no constitutional 
symptoms from their infection but states that in his own 
experience 65% of women and 42% of men have constitutional
symptoms. Burke*s (7) figures agree with those of Stokes.
This was the commonest symptom encountered. Fourteen 
cases complained of a sore throat and ten had noticed a 
hoarseness in their voice.
In ten of the cases there were mucous lesions in the mouth 
as well as the laryngeal erythema.
Headache.
All types of headache have been grouped together. Of the 
nine patients complaining of headache eight complained of 
persistent diffuse headache and one of occipital headache. In 
six of the cases the headache was worse at night. No case with 
a localised headache and tenderness, suggesting a localised 
osteitis was encountered.
Malaise.
Nine patients complained of malaise,. usuaLly accompanied 
by some lassitude. In all cases, malaise was accompanied by 
other constitutional symptoms.
Loss of Weight.
Six patients gave a history of loss of weight, the amounts 
varying from three pounds to twenty pounds. This was a 
difficult sign to assess accurately as most soldiers have a 
very vague idea of their normal weight. As far as could be 
ascertained the average loss of weight in these cases was 6.2 lbs
In one case the loss of weight was 20 lbs. The patient 
had florid secondary syphilis with mucous lesions, a rupial 
syphilide, sore throat, headache, malaise, feverishness and 
aching in the muscles of his limbs.
(58.)
Feverishness.
Of the four patients complaining of feverishness all had 
temperatures above normal. The highest was 100.2 deg. P. 
and the average was 99.4 deg. P.
Myalgia.
Two patients complained of muscular pains. One complained 
of pains in the shoulder girdle and the other of pains in the 
muscles of all four limbs. Both cases reported that these 
pains were worse at night.
Bone Pains.
One patient in the 50th week of his infection complained 
of pain in his right tibia oust below the tibial spine. There 
was a small area of tenderness at this point. The pain was 
worse after exercise. He did not give the typical history of 
nocturnal pain relieved by movement of the affected part. 
Radiological investigation revealed no bony abnormality.
(59)
CONCLUSIONS,
From the preceding study and analysis of this series of
cases, the following conclusions can be reached:-
1. The average incubation period of primary syphilis is 28.4 
days and the incubation period varies from 10 to 92 days.
2. The commonest site for a primary chancre is on the glans 
penis and prepuce.
3. The characteristics of a primary chancre vary greatly, the 
appearances being affected by the site and age of the
chancre and by the presence or absence of secondary infection. 
Certain diagnosis cannot be made from clinical criteria 
alone.
4. The consistency of enlarged lymph glands due to a syphilitic 
infection depends on the size of the glands. The glands 
feel ”shotty” if smaller than the size of a bean and have ax 
”india-rubber” consistency if larger than a bean.
5. Diagnosis by examination cf serum from unhealed primary 
chancres can be made in 94% of cases irrespective of 
whether or not the chancre has been subjected to local 
treatment.
6. The Wassermann Reaction of the blood is positive in 40% of 
cases after the chancre has been present for two weeks. This 
climbs to a 100% during the follomng three weeks.
7. Secondary syphilitic rashes occur in the following order 
and stage of infection:-
(60)
Macular rashes • • • 11.2 weeks
Papular rashes • • * 15.0 weeks
Pustular rashes 
Ecthymatous rashes • • + 26.3 weeks
24.5 weeks
8. Mucous lesions are seen most commonly on the tonsils and 
"buccal mucosa and their average incubation period from the 
date of infection is 12.2 weeks.
9. Condylomata lata occur most frequently around the peri-anal 
region and scrotum and the average incubation period from th 
time of infection is 22.3 weeks. Moist papules are seen 
most frequently on the scrotum and the shaft of the penis 
and the average incubation period is 16.8 weeks.
10. Generalised enlargement of the lymphatic glands occurs 
about the tenth week of infection and the glands feel 
s^hotty**.
11. Only ,33.3 per cent of cases suffering from secondary 
syphilis had constitutional symptoms.
12. No cases with proved bony lesions occurred in this series.
13. Syphilis as studied in this series of cases is a less virulent 
disease than that described by Hutchinson, Fournier and 
Ricord in the Nineteenth Century.
(61)
S E C  I I O H  II.
(62)
SECT ICH IX.
A STUDY OF THE REVERSAL OF THE SEROLOGICAL REACTION 0? THE BLOOD 
IN RELATION TO TREATMENT WITH VARIOUS SCHEDULES OR TRIVALENT 
ARSENICAL- COMPOUNDS AND WITH PENICILLIN.
I N T R O D U C T I O N .
Unlike late syphilis, the treatment of the majority of cases 
of early syphilis permits and encourages standardisation.
Treatment schedules with arsenic and "bismuth usually follow one 
of two systems. In the continuous alternating system "blocks 
of arsenical and "bismuth injections alternate without rest periods 
until treatment is complete. With the concurrent intermittent 
system, arsenic and "bismuth are given concurrently and a rest 
period is given "between each "block of injections.
In general the latter system is used in British practice and 
the continuous alternating system is advocated and adopted in 
America, !h
In the British Army the concurrent intermittent system is 
used. Treatment is divided into unit courses "by rest periods 
of four weeks. In each unit course arsenic and "bismuth are giver; 
on the same day, once a week, for ten weeks except for the first ! 
two injections of the first course. The initial injections are ; 
given while the patient is in hospital.
It was recommended that all sero-negative cases of primary 
syphilis should receive four courses of arsenic ana "bismuth, 
provided the serological tests remained negative throughout 
treatment. Other cases of wearly” syphilis should receive onree^
(63)
full courses of arsenic and "bismuth after the Wassermann 
Reaction has "been fotmd to he negative, serological tests "being 
perf owned at the beginning of each course, (ll). ifBarly,J syphilis 
is diagnosed within the first four years of infection.
The arsenical preparations in routine use are various 
proprietary preparations of neoarsphenamine.
In the first unit course the initial dose is 0.45 g. and 
the subsequent nine weekly doses are 0.6g. In cases of secondary 
syphilis where certain vital structures, e.g. the larynx, are 
involved and in which a Herxheimer reaction might produce a fatal 
obstruction the initial dose is reduced or only bismuth is given, 
on the first day of treatment.
The bismuth preparations, in routine use are either a 
suspension of bismuth metal in isotonic glucose or bismuth 
ossychloride suspended in a glucose solution. In this study the ; 
preparation used throughout was bismuth osychloride, so that 
the effect of the bismuth injections would be constant.
During the 1914 - 1913 war it was found that a reduction 
in the amount of arsphenamine given in a unit course reduced 
the incidence of jaundice and dermatitis (12). In 1942 the 
routine in the Army was modified in an attempt to reduce the 
incidence of jaundice.
The courses given were as follows
  ---------- ............... -— 4*.
Neoarsphenamine- Bismuth.
1 0.45g. o.Sg.
5 0.6g. O.Sg.
12 0.6g. * 0.5g.
19 Nil o.Sg.
2® 0.6g. 0.3g.
53 Nil O.Sg.
40 0.6g. O.Sg.
47 Nil O.Sg.
54 0.6g. O.Sg.
61 0.6g. 0.3g.
Total arsenic = 4.05g.
Course 2 only.
1 Nil O.Sg.
5 Nil O.Sg.
12 0.6g. O.Sg.-
19 0.6g. O.Sg.
S6 0.6g. 0.3g.
53 0.6g. O.Sg.
40 Nil O.Sg.
47 0.6g. 0.2g.
54 0.6g. 0.3g.
61 0.6g. O.Sg.
Total arsenic » 4.2g.
It wiH.be shown in Section III of this study that the 
reduction in the total amount of neoarsphenamine given in
(65)
these modified unit courses did not reduce the incidence of 
jaundice in the series of cases studied.
At the time when jaundice assumed epidemic proportions in 
the cases attending for anti-syphilitic treatment it was found 
that jaundice usually occurred during the rest period after the 
first course or about the beginning of the second course. The 
first two arsenical injections of the second course were there­
fore omitted to prevent adding further insult to a possibly 
already damaged liver.
Owing to the movements of military personnel from one 
station to another, it hasbeen impossible to make any long term 
study of the results obtained from routine treatment schedules.
A study of the results obtained from various unit courses has, 
however, been carried out by assessing the changes in the 
serological reaction of the blood thirteen weeks after treatment 
was started.
Prebble has described a unit course in which neoarsphenamin 
and bismuth are given bi-weekly (13). He has reported 
consistent reversal of the serological tests with this course.
A series of cases was treated according to this schedule with 
the object of obtai, ning a yard-stick by which the results of 
other unit course studied, might be measured.
An analysis of six different schedules, covering a series 
of 829 cases of primary and secondary syphilis haqfbeen made.
All serological tests were Wassermann Reactions carried 
out at the same laboratory and using the Medical Research 
Council Method 1.(14). Where -Rahn Tests are mentioned, the
(66)
technique was a two tube method containing anti gen-serum 
mixtures of 1 in 12 and 1 in 6. The blood for the serological 
tests was obtained on the day that the diagnosis was made and 
treatment commenced. The tests were repeated at the beginning 
of the second course following the rest period. The second 
Wassermann Reaction was thus carried out in the thirteenth week 
after the beginning of treatment.
As a further comparison the follow-up on 160 cases of early 
syphilis treated with penicillin has been included. The cases 
in this group were diagnosed and treated by me in The Central 
Mediterranean Forces. Wassermann Reactions could not be 
obtal ned. Kahn tests only were carried out in this series.
(67)
Unit Course No, 1.
This course was that described by Prebble and consisted of 
twice weekly injections of neoarsphenamine and bismuth 
oxychloride (13). It extended over thirty nine days and a 
rest period of six weeks was given between courses. The number 
of cases treated in this way was 205.
Dav ITeoarsuhenamine Bismuth Oxychloride
1 0.3g. 0.2g.
4 0.45g. 0.2g.
8 0.3g. 0.2g.
11 0.45g. 0.2g.
15 0.3g. 0.2g.
18 0.45g. 0.2g.
22 0.3g. 0.2g.
25 0.45g. 0.2g.
29 0.3g. 0.2g.
32 0.45g. 0.3g.
36 0.3g. 0.2g.
39 0#45g. 0.2g.
Total neoarsphenamine = 4.5g.
The group of 205 cases treated with this course was 
divided into four groups according to the clinical findings 
and the serological reactions before treatment, as follows:-
(68)
(a) Sero-negative primary syphilis.
(b) Sero-doubtful primary syphilis.
(c) Sero-positive primary syphilis.
(d) Secondary syphilis.
The results of the Wassermann Reaction performed during the 
thirteenth week after treatment was commenced, are tabulated 
below: -
(a) In 66 cases of.Sero-negative primary syphilis:
No. Per cent.
Sero-positive Nil Nil
Sero-doubtful Nil Nil
Sero-negative 66 100
(b) In 11 cases of sero-doubtful primary syphilis:
No. Per cent.
Sero-positive Nil Nil
Sero-doubtful Nil Nil
Sero-negative 11 100
(c) In 90 cases of sero-positive primary syphilis:
No. Per cent.
Sero-positive 1 1.1
Sero-doubtful 4 4.4
Sero-negative 85 94.4
(d) In 38 cases of secondary syphilis:
No. Per cent.
Sero-positive 3 7.9
Sero-doubtful 3 7.9
Sero-negative 32 84.3
(69)
The total number of sero-positive and sero-doubtful cases 
was 139. The number of cases undergoing complete serological 
reversal was 128 ov92% at the thirteenth week after the 
commencement of treatment.
The average incubation periods in groups (c) and (d) were 
calculated with a view to estimating whether reversal of the 
serological reaction of the blood was directly affected by the 
duration of the infection. The incubation periods are given 
below.
(c) In 90 cases of sero-positive primary syphilis, the results 
of the Wassermann Reaction at the 13th week of treatment and 
the incubation periods, were as follows:-
(a) In 38 cases of secondary syphilis the results of the
Wassermann Reaction at the 13th week of treatment and the 
incubation periods were as follows:-
Sero-positive 
S e r o-doub tful
Incubation period 
42.0 days 
47.25 days
Sero-negative 43.82 days
Sero-positive 
S ero-doub tful
64.33 days
55.33 days
Sero-negative 66.00 days.
(70 )
Unit Course No. 2.
This course has already "been described in detail in the 
introduction to this section, and was in routine use in the Army 
between 1942 and 1944. The total neoarsphenamine given was 
4.05g. and the total bismuth oxychloride 2.5g. The course
covered a period of 61 days and was followed by a rest period 
of four weeks before the second course. The results of the 
changes in the serological reactions as determined at the 
beginning of the second course in 129 cases are tabulated below:
(a) In 38 cases of sero-negative primary syphilis:
No. Per cent.
Sero-positive 1 2.6
Sero-doubtful 5 13.0
Sero-negative 32 84.3-
(b) In 9 cases of sero-doubtful primary syphilis:
No. Per cent.
Sero-positive Nil Nil
Sero-doubtful 1 11.0
Sero-negative 8 89.0
(c) In 51 cases of sero-positive primary syphilis:
No. Per cent.
Sero-positive 2 2.0
Sero-doubtful 10 20.0
Sero-negative 39 78.0
(71)
(&) In 31 cases of secondary syphilis:
No* Per cent.
Sero-positive 5 16*0
Sero-doubtful 10 32*2
Sero-negative 16 51.2
The total number of sero-positive and sero-doubtful cases 
was 91. The number of cases undergoing complete serological 
reversal at the thirteenth week of treatment was 63 (69%).
( 7 2 )
Unit Course No, 5.
The third course in this study was as fol3.ows:-
Day Neoarsnhenamine Bismuth Oxvchloride
1 0*45g. 0.2g.
4 0*45g. 0.2g.
9 0.45g. 0.2g.
16 0.45g. 0.2g.
23 0.45g* 0.2g.
30 0.45g. 0*2g.
37 0.45g. 0.2g«
44 0.45g. 0«2g.
51 0.45g, 0.2g.
67 0.45g. 0*2g.
Total neoarsphenamine = 4.5g.
A group of 164 cases was treated v/ith this unit course. 
The results of the Wassermann Reaction performed on the 
thirteenth week after the commencement of treatment are 
analysed "below.
(a) In 62 cases of sero-negative primary syphilis:
No. Per cent.
Sero-positive 2 3*2
Sero-doubtful 3 4.8
Sero-negative 57 91.2
(73)
(b) In 6 cases of sero-doubtful primary syphilis:
No. Per cent.
Sero-positive Nil Nil
Sero-doubtful Nil Nil
Sero-negative 6 1 00
(c) In 62 cases of sero-positive primary syphilis:
No. Per cent.
Sero-positive 5 8.0
Sero-doubtful 9 14.4
Sero-negative 48 76.8
(d) In 34 cases of secondary syphilis:
No. Per cent.
Sero-positive 6 17.6
Sero-doubtful 9 26.5
Sero-negative 19 55.9
Total sero-positive and sero-doubtful cases numbered 102. 
The number of cases undergoing complete serological reversal 
"by the thirteenth week was 73 (71$).
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Unit Course Ho. 4,
This course was similar to Course Wo. 3 except that after 
the initial dose of 0.45g. neoarsphenamine the subsequent nine 
injections of arsenic were 0.6g.
Day Neoarsphenamine Bismuth Oxvchloride
1 0.45g. 0.2g.
4 0.6g. 0.2g.
9 0.6g. 0.2g.
16 0.6g. 0.2g.
23 0.6g. 0.2 g.
30 0.6g. 0.2g.
37 0.6g. 0.2g.
A A
•Lai 0 . 6g. 0.2g.
51 0.6g. 0.2g.
67 0.6g. 0.2g*
Total neoarsphenamine = 5.85g.
171 cases were treated with this unit course. The results 
of the Wassermann Reactions performed on the thirteenth week 
after treatment was commenced are analysed below.
(a) In 64 cases of sero-negative primary syphilis:
No. Per cent.
Sero-positive 1 1.6
Sero-doubtful 2 3.2
Sero-negative 61 95.3
(75)
Ob) In 5 cases of sero-doubtful primary syphilis:
No. Per cent.
Sero-positive Nil Nil
Sero-doubtful Nil Nil
Sero-negative 5 100
(c) In 64 cases of sero-positive primary syphilis:
No. Per cent.
Sero-positive 2 3.2
Sero-doubtful 2 3.2
Sero-negative 60 93.7
(d) In 38 cases of secondary syphilis:
No. Per cent.
Sero-positive 8 13.1
Sero-doubtful 5 21.0
Sero-negative 25 66.0
Total sero-positive and sero-doubtful cases numbered 
107. Oases undergoing complete serological reversal at the 
thirteenth week after the beginning of treatment numbered 
90 (84$).
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Unit Course Ho. 5.
This course consisted of twice weekly infections of 
Mapharside and weekly infections of "bismuth oxychloride.
Manharside Bismuth Oxvchloride
1 0.04g. 0.3g.
4 0*06g. Nil
8 0.04g* 0.3g.
11 0*06g* Nil
15 O.Q4g. 0.03g.
18 0*06g. Nil
22 0.04g* 0.03g.
25 0.06g. Nil
29 0.04g. 0*03g*
52 0*06g. Nil
36 0*04g. 0.03g*
59 0.06g* Nil
Total Mapharside = 0*6g.
Only a small group of 50 cases ?rats treated with this unit 
course* The results of the Wassermann Reactions performed in 
the thirteenth week after ^ treatment commenced are analysed "below
(a) In 20 cases of sero-negative primary syphilis:
No* Per cent*
Sero-positive Nil Nil
Sero-doubtful Nil Nil
Sero-negative 20 100
(77)
(b) There were no cases of sero-doubtful primary syphilis 
in this group,
(c) In 25 cases of sero-positive primary syphilis:
No, Per cent.
Sero-positive Nil Nil
Serodoubtful 2 8
Sero-negative 23 92
(d) In 5 cases of secondary syphilis:
No. Per cent.
Sero-positive Nil Nil
Sero-doubtful Nil Nil
Sero-negative 5 100
Total sero-positive and sero-doubtful cases numbered 30. 
The number of cases undergoing complete serological reversal at 
the thirteenth week after commencing treatment was 28 (93%).
4
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Unit Course Ho. 6.
Unit Course No. 6 lasted nine and a half weeks, during 
which 1.2g. of Mapharside were given in tv/ice weekly doses of
0.06g. Weekly doses of 0.2g. of "bismuth osychloride were 
given in conjunction with the arsenic.
Mapharside Bismuth Oxvchloride
1 0.06g. 0.2g.
4 0.06g. Nil
7 0*06g. 0.2g.
10 0*06g. Nil
14 0#06g. 0.2g.
17 0.06g. Nil ■
21 0.06g. 0.2g.
24 0*06g. Nil
28 0#06g. 0.2g.
31 0.06g. Nil
35 0.06g. 0.2g.
38 0*06g. ‘ Nil
42 0.06g. 0.2g.
45 0.06g. Nil
49 0.06g. 0.2g,
52 0.06g. Nil
56 0.06g. 0.2g.
59 0.06g. Nil
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Unit Course No. 6 (Continued).
Day Mapharside. Bismuth Oxvchloride.
63 0.06g. 0.2g.
67 0.06g. Nil
Total Mapharside = 1.2g.
A 100 cases were treated with this unit course as outlined 
and the results of the Wassermann Reaction carried out in the 
thirteenth week after treatment commenced, are analysed "below.
(a) In 30 cases of sero-negative primary syphilis:
Sero-positive 
S ero-doubtful 
Sero-negative
("b) In 13 cases of sero-doubtful primary syphilis:
No. Per cent.
Sero-positive 3 23
Sero-doubtful Nil Nil
Sero-negative 10 76
(c) In 36 cases of sero-positive primary syphilis:
No. Per cent.
Sero-positive Nil Nil
Sero-doubtful 3 8#4
Sero-negative 33 91.6
No. Per cent.
Nil Nil
7 23.3
23 76.6
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(&) In SI cases of secondary syphilis:
No, Per cent.
Sero-positive 1 4.7
S er o-douh tful Nil Nil
S ero-negati ve 20 95.5
The total sero-positive and sero-doubtful cases numbered 
70. The number of cases undergoing complete serological 
reversal thirteen weeks after treatment was commenced, was 
63 {90%).
Penicillin Schedule No. 1.
The total amount of penicillin administered to each case in 
this group was 2,000,000 Oxford Units of penicillin. One 
hundred injections of 20,000 Oxford Units were given at intervals 
of three hours for three hundred hours. Kahn Tests only v/ere 
carried out at the beginning of treatment and at the thirteenth 
week. No other anti-syphilitic drugs were given. 52 cases vrere 
treated by this schedule and the results of the Kahn Tests are 
analysed below.
(a) In 23 cases of sero-negative primary syphilis:
No. Per cent.
Sero-positive Nil Nil
Sero-doubtful Nil Nil
Sero-negative 23 100
(b) In 4 cases of sero-doubtful primary syphilis:
No. Per cent.
Sero-positive ~ Nil Nil
Sero-doubtful Nil Nil
Sero-negative 4 100
(c) In 15 cases of sero-positive primary syphilis:
No. Per cent.
Sero-positive 3 20
Sero-doubtful Nil Nil
Sero-negative 12 80
Per oent.
40 
Nil 
60
The total number of sero-positive and sero-doubtful cases 
was 29. Oases undergoing complete serological reversal at the 
thirteenth week after the beginning of treatment numbered 
22 (75.8?S).
In this series, twenty cases were followed up for a period 
of sic months. Kahn Tests were negative in 18 cases as were 
the findings in the cerebro-spinal fluid when examined at six 
months. Two of the cases relapsed and were retreated.
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(d) In 10 cases of secondary syphilis:
No.
Sero-positive 4
Sero-doubtful Nil
Sero-negative 6
(83)
Penicillin Schedule No. 2.
In this schedule the total amount of penicillin administered 
was 2,400,000 Oxford Units. 30,000 Oxford Units were given 
every three hours for a period of ten days. Kahn Tests were 
carried out at the beginning of treatment and at the thirteenth 
week after the beginning of treatment. No other anti-syphilitic
drugs were given. The results of the Kahn Tests in 108 cases
are analysed below. j
!
(a) In 56 cases of sero-negative primary syphilis: j
iI
No. Per cent. |i
Sero-positive 2 3.6
Sero-doubtful Nil Nil
Sero-negative 54 97.2
(b) In 9 cases of sero-doubtful primary syphilis:
No. Per cent.
Sero-positive Nil Nil
Sero-doubtful ' 1 11.1
Sero-negative & 88.8
(c) In 33 cases of sero-positive primary syphilis:
No. Per cent.
Sero-positive 6 18.3
Sero-doubtful 3 9.3
Sero-negative 24 72.3
(d) In 10 cases of secondaiy syphilis:
No. Per cent.
Sero-positive 2 20
Sero-doubtful Nil Nil
Sero-negative 8 80
(84)
The total number of sero-positive and sero-doubtful cases 
was 52. The number of cases undergoing complete serological 
reversal thirteen weeks after treatment was commenced was 
40 (76.9/S).
In this series of cases 64 were followed up for a minimum 
period of six months. Ten cases relapsed and were retreated 
during this period.
A graph showing the percentage of cases undergoing complete 
serological reversal thirteen weeks from the commencement of 
treatment with the various courses and schedules described 
above is attached.
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D3S CPSSIOH.
1. For the purposes of this study, patients suffering from 
primary or secondary syphilis v/ere alone included. Any 
patient who, for whatever reason, failed to receive his 
allotted treatment according to schedule, was excluded from the 
series. In every other respect the cases were unselected.
In all, the groups treated with neoarsphenamine total 8X9 
cases, and 160 cases v/ere treated with penicillin, a total 
of 979 cases.
2. As stated, the blood for serological tests was taken on the I
day treatment was commenced and again thirteen weeks later; !
I
the tests were performed in the same laboratory and under 
comparable conditions.
3. The table below presents the percentage composition of sero­
negative and sero-positive cases for each group of patients 
treated by the various unit courses. For this purpose sero- |
i
doubtful results are included with sero-negative reactions. J
I
With the exception of G-roup No. 5 it will be noted that the j
percenter e of sero-negative and sero-positive cases in each
group is relatively constant. It is reasonable therefore to j 
use these groups for comparing the sero-reversal obtained by j 
the unit courses described.
Unit Course No.l No.2 No. 3 No.4 No. 5 No. 6
fo of sero-negative 
and sero-doubtful 
cases
37.3 36.9 41.4 40.0 50.0 43.0
% of sero-positive 
cases.
62.5 68.1 58.6 60.0 50.0 57.0
(87)
4. Graph No.3 shows the percentage of serological reversal in 
the groups of cases treated with Unit Courses Nos. 1 to 6.
In Courses Nos. 1 and 3 the total weight of arsenic administered 
is the same, consisting of one injection twice wedcly for six 
weeks (12 injections) in Course No. 1 while in Course No. 3 it
|
is administered in ten injections at weekly intervals. Course 
No. 1 resulted in 92% of sero-reversal while Course No. 3
I
only achieved 71%. j
I
5. Courses Nos. 3 and 4 both comprised ten injections of neo- j 
arsphenamine at weekly intervals but in Course No. 5 the total! 
weight administered was 4.5g. of neoarsphenamine while in j 
Course No. 4 the total weight was 5.85g. Serological reversalj 
in the latter was 84% while in Course No. 3 sero-reversal \
s
occurred in only 71% of cases. j
6. In Courses No. 1 and No. 2 in which the arsenic and bismuth j
j!
are almost identical serological reversal occurred in 92% 
treated by Course No. 1 and. 69% treated by Course No. 2.
This difference suggests strongly that arsenical injections am 
therapeutically more effective when administered at regular j 
intervals without intermissions as occured in Course No. 2 
at the 4th, 6th and 8th weeks of treatment. !
7. Only one conclusion is justifiable from a study of the results 
obtained by Courses Nos. 5 and 6 in view of the fact that the 
composition of Group 5 is not comparable with the other 
groups, namely, that equaL ly good results as juuged by > 
serological reversal are obtainable by the use of mapharside.
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8. It will "be noted that in Courses Nos. 3 and 4 the bismuth 
factor is identical both in regard to total dosage, number 
and intervals of injections. This factor is not identical 
in Unit Courses Nos. 1 and 3. It tould of course have been 
ideal to eliminate bismuth entirely from all these treatment 
courses, but such a step was not practical in the present 
investigation. Bismuth being an insoluble drug forming
on injection, a depot in the muscles from which regular 
absorption takes place, the difference may reasonably be 
discounted.
9. Schedules 1 and 2 comprise 160 cases of primary or secondary 
syphilis. With the exception of the total number of 
penicillin units administered the results in Schedules 1 and 
2 are strictly comparable.
(89)
OOHOLPSIQMS.
Judged from the complete reversal of the serological
reaction 15 weeks after treatment was commenced
1. Using weight for weight of neoarsphenamine a higher percentage 
of serological reversal is obtained "by giving the drug twice 
weekly rather than once weekly, (See Discussion para. 4)
2. The percentage of cases achieving complete serological 
reversal is proportional to the weight of neoarsphenamine 
administered. (See Discussion para. 5)
5. Neoarsphenamine should he administered at regular intervals 
without intermissions to achieve a high percentage of 
serological reversal. (See Discussion para. 6)
4. Satisfactory results in the reversal of the serological 
reaction can he obtained with mapharside.
5. A total dosage of 2,400,000 Oxford Units of penicillin is not 
adequate treatment for all cases of primary and secondary 
syphilis. As there is no significant difference obtained
in serological reversal by 2,400,000 Oxford Units as compared 
with 2,000,000 Oxford Units given over the same period (300 
hours) it will probably be necessary not only to increase the 
total dosage of penicillin but also to consider the importance 
of the wtime/dosageM factor.
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SECTION III,
A STUDY OP THE MAJOR REACTIONS TO T RIVAL ENT ARSEHDAL■Mfc——h— — ^—r—,—B |, iT inf n» rig iw ir ir'<riniiiii>" i^Mf'»i*-i» iw n« m t i —n nn
QOMPOUNDS AND AN INVESTIGATION INTO NEW METHODS OP 
MANAGEMENT OF THESE REACTIONS.
I N T R O D U C T I O N .
Major reactions arising from arsenotherapy postpone the 
completion of adequate treatment and prejudice the prognosis in 
cases of early syphilis. Also, in civil practice, these 
reactions encourage default and add to the difficulties of case- 
holding. These disadvantages are perhaps less important now 
that penicillin is available "but still remain significant.
Such reactions to treatment may follow the use of the 
trivalent arsenical preparations and are here divided into two 
groups according to their aetiology and management.
GROUP I: Jaundice; excluding icterus associated with Milianfs
erythema of the 9th day.
GROUP II: (a
Cb
(c
(a.
(e
(f
(g
Milian1 s syndrome of erythema of the 9th day. 
Ilaemorrhagic encephalopathy.
Agranulocytosis.
Aplastic anaemia.
Arsenical purpura.
Dermatitis (excluding exfoliative dermatitis). 
Exfoliative dermatitis.
It will he shown that the jaundice mentioned in Group I 
being of infective origin, can be prevented. Generalised
( 9 2 )
dermatitis with exfoliation is dealt with separately because a 
new method of management, as compared with the other reactions 
in this group, has been studied.
The incidence of many of the reactions in Group II may he 
reduced by attention to detail in the choice, preparation and 
administration of the arsenical preparations combined with 
alertness in detecting the prodromata which may herald their 
appearance. Thus sulpharsphenamine is known to be followed 
more often by blood dyscrasias and dermatitis than is the case 
with neoarsphenamine. Again, in addition to using a batch of 
drug well within the manufacturers expiry date, care must be 
taken to avoid oxidation both in its preparation and by 
immediate administration. It is a sine qua non that the !
injection must be wholly intravenous and no perivenous leak 
permitted. Warning of impending dermatitis and blood 
dyscrasias may be obtained by careful questioning and examinatioi 
of the patient before each injection.
j
Hitherto, many of these cases have been regarded as j
unsuitable for further treatment with the trivalent arsenical |
drugs. In this section a method will be described whereby 
such treatment can be quickly resumed.
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GROUP I.
3jgu?i4iQQ;..'.excluding: icterus associated with Miliants 
erythema of the 9th day.
Introduction,.
Jaundice has "been recognised as occurring in the course of 
syphilis for at least four centuries. Following the introductLcn 
of the arsenical compounds "by Erlich in 1910, jaundice occurring 
during treatment with these drugs has "been more frequently
>
reported under the title of post-arsphenamine jaundice, as it 
was thought to "be a toxic effect on the liver cells.
Since the 1914 - 18 War there have "been epidemics from time 
to time, all over the world, of what has "been termed catarrhal j |  
jaundice "but which now would "be termed infective hepatitis, 
since epidemiological studies and experimental investigation 
have proved that the condition is infective in origin and j
probably spread by droplet infection. (22, 71, 72). Until the i 
1939 - 45 War the incidence of post-arsphenamine jaundice was j
generally reported as being less than 0.2% (15) although in one i
i
paper an incidence of 50.18% was given. (29). j
Epidemiological studies suggest that infective hepatitis ! 
has an incubation period of from three to five weeks. It is | 
spread by droplet infection during close but not necessarily j
prolonged contact and occurs most frequently in children and j
young adults. One attack confers immunity on the individual 
and second attacks are rare (72). Homologous serum jaundice 
occurs after the injection of pooled plasma, whole "blood.
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convalescent serum and yellow fever vaccine (17, 18, 19, 21).
It has an incubation period of from two to four months and
cannot he differentiated pathologically or clinically from
infective hepatitis although it has heen pointed out hy 
Hawley (19) that homologous serum jaundice may he associated 
with a greater incidence of allergic phenomena.
Post-arsphenamine jaundice occurring during the treatment 
of syphilis with the arsphenamines may he divided into two types. 
The first occurs during the seven to fourteen days following the 
first injection of arsenic and is prohahly an allergic phenomenor 
associated with Milian*s syndrome of the 9th day. This type wil] 
he discussed later. The second variety has an incubation |
period of from two to four months and is indistinguishable |
clinically and pathologically from infective hepatitis (20,21,22^! 
It is this latter, more common variety which is considered in ;| 
this section. i j
J.
Theoretically post-arsphenamine jaundice may he due to |
I
four causes:- 1
I
1. To syphilis. |
f2. To the direct or indirect action of the organic I
arsenical preparations used in treatment. I
3. To an infective agent. j
4. To any combination of the above three causes. I
I
I
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1. Jaundice occurs as a rarity during the course of untreated 
syphilis and clears up quickly vrith specific treatment. (5, 15) 
The incidence in different clinics would not vary so widely as 
from 0.1# to 50/6 nor would it occur after a period of treatment 
varying from ten to eighteen weeks.
2. It is well recognised that arsenic is detoxicated in the 
liver and many have assumed that post-arsphenamine jaundice was 
due to liver damage arising from the arsenic. It has been shown 
that hepatitis can be produced in animals by large doses of the 
arsphenamines. The dose, however, is far beyond the therapeutic 
level (26). The incidence of post-arsphenamine jaundice is 
independent of the preparation used and within the therapeutic 
limits independent of the dosage, also the incidence varies from 
clinic to clinic and from time to time in the same clinic 
although the drugs and dosage used remain constant (73). It is |
considered therefore that arsphenamine per se has little, if [
i
any effect on the incidence of post-arsphenamine jaundice. |
It has been shown experimentally that the liver can be 
protected from damage by the arsphenamines by diet and that 
certain aminoacids, particularly methionine, protect the liver j 
from chloroform in protein depleted dogs (23, 26). Beattie and ;| 
Marshall have reported on the prevention and treatment of post- j 
arsphenamine jaundice with methionine with rather inconclusive j 
results (24). Darmady has reported on the treatment of j
infective hepatitis with a high protein diet with similar
results (25). The reduction of protein in the diet during the t 
1939 - 45 war is unlikely to lie a significant factor as the |
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incidence of this complication has "been reported as 50% in a 
clinic in 1934 (29). It is considered that while diet may play 
a part in the aetiology of post-arsphenamine jaundice, it is an 
unimportant factor.
3. In early 1943 MacGullum (27) and Biggar (28) suggested that 
jaundice might "be caused "by an infective agent passed from patienl 
to patient via the syringes used in intravenous treatment.
Biggar drew attention to the fact that in many venereal disease 
clinics, syringes were few and were not adequately sterilised 
"between each injection. A common practice was to "boil the 
syringe at the "beginning of each out-patient session only, or 
even to omit this, the syringe "being left in spirit for twenty 
four hours prior to the session. The practice was to first wash; 
out the syringe in an antiseptic fluid and then in sterile water ; 
"between each injection. Biggar showed "by "bacteriological 
experiments using staphylococci that these methods were 
insufficient to rid the syringe of "bacterial contamination. 
Frequent washings did not remove aU "bacteria from the syringe, 
maiy lodging around the head of the plunger.
Ruge (16) has shown from epidemiological data from the ,
German Navy "between 1918 and 1930 that the rise in incidence of 
post-arsphenamine jaundice was almost parallel to that of
infective hepatitis.
Logically, the hypothesis that post-arsphenamine jaundice 
might "be due to the virus of infective nepatitis, syringe 
transmitted, arose following Biggar's work. In the summer of 
1943 Col. Sheehan, Deputy Director of Pathology, Western Command
collected evidence to support this hypothesis. His evidence 
briefly was as follows:-
( (a) In 80 female patients treated in a clinic in which syringes 
were immersed in strong antiseptic solution for fifteen 
minutes between each injection, only two patients developed 
jaundice. It is probably significant that both these 
patients received some of their injections in another clinic.
(b) In a male clinic with a current incidence of jaundice of 
about 75%, five patients received all their injections with 
carefully sterilised syringes and meticulous precautions werei 
taken to prevent contamination of these patients with blood 
from others. These five cases v/ere observed for periods 
varying from 15 to 27 weeks and none developed jaundice. i
(c) In a prisoner of war camp 34 cases were receiving anti­
syphilitic treatment. It happened that these cases were 
treated in two groups. One group was treated on a Wednesday! 
and the other on a Friday. The allocation of patients to 
either group was fortuitous but once started in a particular 
group the patient remained in it throughout his subsequent 
treatment. Apart from the one variable factor of the day of 
treatment all other dietetic, environmental, drug and dosage 
factors were identical. Syringes were sterilised by 
boiling at the beginning of the clinic on Wednesday and on 
Friday but were only washed out between each injection in 
the group. There was thus an opportunity for transmitting a 
blood borne infection among members of one group but not of 
transmitting infection from one group to the other. One
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patient, introduced into the Wednesday group, had received anti­
syphilitic treatment elsewhere and was already developing 
hepatitis* In due course he developed jaundice* Subsequently 
eight other men in the Wednesday group developed hepatitis hut 
the patients in the Friday group remained free.
(d) Over a period of tv/elve months, three special treatment orderlies 
employed in a syphilis clinic, who from time to time had their 
hands contaminated with “blood from the patients, developed 
typical hepatitis. Again, three laboratory assistants engaged 
in separating serum for serological tests from the blood of 
patients under treatment, developed hepatitis* None of these 
six cases had received any arsenical injections nor had they 
received any inoculations with unsterile syringes. During this 
period of twelve months cases of post-arsphenamine jaindice in 
the clinic were frequent. It is possible that infection gained 
entrance through small abrasions in the skin of their hands.
(e) Small out~breaks of jaimdiee have been.recorded in the past 
amongst groups of patients subjected to venepuncture; e.g. in 
a diabetic clinic, in a clinic for rheumatoid arthritis where 
gold salts were, administered and in a sanatorium where monthly 
estimations of the blood sedimentation rate were performed. In 
the light of recent knowledge it seems probable that these were 
all examples of infective hepatitis spread by syringes 
contaminated with ictero-genic serum.
Following consideration of this evidence, Major Laird, 
Command Specialist in Venereology, Western Command, applied for
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War Office authority to carry out a special investigation at a 
Military Hospital. He stipulated that this investigation 
could only he carried out if the following conditions were 
guaranteed
1. A special centre should he designated to perform the research.
2. One Medical Officer should he placed in sole charge of the 
work and should not he posted until the trial had been j  
completed. A speciaL ly selected and. trained team should be j
i
given similar security of tenure. j
3. The number of syringes and needles and the facilities for j
I
their sterilisation by boiling must be adequate. j
E
4. The patients treated in this centre must not receive any I
i
injections or have blood taken for serological tests elsewherej 
This meant that treatment must be initiated and maintained j 
for at least six months at this special centre, even j
immunisation and vaccination must not be undertaken elsewhere, j
5. Authority must be obtained for such patients to be attached j 
to units in the vicinity of the special treatment centre
and they must not be posted thence for at least six months.
In view of the importance attached to the investigation of 
post-arsphenamine jaundice, authority to fulfil these conditions j 
was granted and I was placed in charge of the work, being 
responsible for the training of the team and supervision of the ' 
technique. All intravenous injections'were given personally.
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The object of the Investigation.
The investigation was undertaken to test the hypothesis 
that post-arsphenamine jaundice v/as caused by a virus infection 
passed from patient to patient by contaminated syringes. Direct 
proof of this hypothesis was not practical, but it was believed 
that if the incidence of post-arsphenamine jaundice which was 
then approximately 50% could be greatly reduced by the use of a 
special technique in intravenous injection which prevented the j
transfer of blood and serum from one patient to another, then j
this could be interpreted as indirect proof of the hypothesis, 
provided all other environmental, dietetic and therapeutic factors 
were constant. The special technique had, preferably, to be - 
one v/hich could be carried out in any clinic provided the staff 
and materials were adequate. . \i
\i
A Detailed Description of the Investigation. j
ii
The investigation was carried out in the syphilis out-patienij 
department of a Military Hospital, and the soldiers included in ! 
the investigation were all cases of primary or secondary syphilis| 
in whom the diagnosis had been established by dark-ground 
examination of serum from a primary or secondary lesion. All | 
injections, inoculations and vaccinations were carried out in j 
the clinic using a similar technique to that described below.
The anti-syphilitic treatment given was the standard course 
employed as a routine for early syphilis and was as follov/s: —
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Dav ITeoar snhenamine. Bismuth Oxvchloride.
1 0.45g. 0.2g.
4 0.6g. 0.2g.
9 0.6 g. 0.2g.
16 0.6g. 0.2g.
23 0.6g. 0.2g.
30 0.6g. 0.2g.
37 0.6g. 0.2g.
44<rx 0.6g. 0.2g.
51 0.6g. 0.2g.
58 0.6g. 0.2g.
The second, and subsequent courses, were identical vdth the
first. A rest period of four weeks was given between courses 
and blood for a Wassermann Reaction was taken at the beginning of 1 
each course prior to the first injection of neoarsphenamine in 
the course. The same proprietary preparations of neoarsphenamine 
and bismuth were used throughout the investigation.
During the first two weeks of their treatment, the soldiers 
included in this investigation mingled with other patients in 
the syphilis wards, including patients suffering from post- 
arsphenamine jaundice. Later, as out-patients, they were in 
contact, in the out-patients department, with others who were 
incubating post-arsphenamine hepatitis. All patients were given: 
their injections in the order in which they arrived at the out­
patient department and the same syringes were used for all 
patients receiving treatment whether or not they were included in
(108)
the investigation.
Every patient in the investigation was observed over a 
minimum period of 180 days and the majority were observed for 
longer.
The risk of transmitting infection by intramuscular injectLop 
was considered to be less but the possibility was investigated. 
The first five patients treated we re given their bismuth injection^  
with a boiled needle and syringe and full precautions against 
contamination with blood or serum were taken. The second five 
patients were given their bismuth with a sterile needle and the 
syringe normal ly used for bismuth injections. This syringe was 
boiled only at the beginning of each session. Alternative 
groups of five patients in the investigation were treated 
similarly.
As already stated blood for serological testing v/as taken 
at the beginning of each course. The venepuncture was performed 
under the same conditions as those laid down for the injection of 
neoarsphenamine.
A Detailed Description of the Technique Used in Treatment.
The object of this technique is to prevent contamination 
with blood or serum of one patient and the next, and the basic 
principles are those used in the "bed isolation" of infectious 
cases, with all materials, equipment and staff in a "clean" or 
"contaminated" sta.te. Diagram X shows the lay-out in uhe 
syphilis out-patient department and the routes tdc en by each 
member of the team of three, comprising one Medical Officer and 
two special treatment orderlies.
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One of the orderlies handles only contaminated equipment 
and the other uncontaminated equipment. Any article which has 
"been in contact with a patient is automatically considered to he 
contaminated whether or not it has "been in contact with "blood or 
serum. The Medical Officer is the only member of the team Y/ho 
handles "both contaminated and uncontaminated material and equip­
ment, and he decontaminates himself "between each injection.
The ‘’contaminated Orderly” washes out syringes and needles 
at the sink (see diagram) and checks the needles for patency 
and sharpness. He wraps each washed syringe and plunger in a 
large square of lint. The size of this square is important.
It must he large enough to cover the "breadth of the injection 
table (T.l) and fall about two inches over each side. When a 
number of syringes and needles have been washed and wrapped, 
the syringes separately and the needles in one packet of lint, 
the ’contaminated orderly” places them in the steriliser (St.) 
on table No. 2 (T.2), lowers the tray and switches on the 
current. When the contents have boiled for 20 minutes he 
switches off the current, lifts the lid, raises the tray by 
means of the lever on the steriliser and leaves the contents 
to cool. He does not touch the handles of the tray or the 
boiled syringes and needles. The lint squares are re-used 
many times. Should they become contaminated with blood the 
orderly washes, thou out with soap ano. water at the sink.
The “clean” or “uncontaminated orderly” lifts the tray 
containing the syringes and needles out of the steriliser and 
places them on a table (T.3). He unwraps the syringes in a
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large enamel tray previously sterilised "by flaming, and assembles 
the plungers and barrels on one half of the tray. The squares 
of lint are placed on the other half of the tray. He prepares 
the injection in a sterile galley-pot, previously sterilised by j 
boiling, loads the syringe and attaches the needle, using sterilej 
Gheatlefs forceps. He then holds out by forceps, a square of j 
lint and the Medical Officer takes this without touching the 
forceps and lays it over the injection table. The patient seats! 
himself on the chair in front of the injection table, lays his j 
arm on the lint square and distends the veins of his forearm by j 
compressing his a m  manually. The Medical Officer who has not j
I
yet touched the patient drops some spirit on the arm from the j
!
drop-bottle (D.B.). _ The “uncontaminated orderly” places the 
syringe and needle containing the arsenical injection on to the 
square of lint without touching the lint, Medical dfficer or j
j
patient. The Medical Officer takes the syringe and gives the 
injection. Meanwhile the “uneontamma&ed orderly” has dropped a j 
sterile swab of cotton wool on to the lint square. The patient; 
presses this on his arm over the site of the injection and 
holding his arm above his head leaves his seat and goes to the 
bucket for contaminated swabs (B.). When he is sure that all 
oozing from the venepuncture has ceased he drops the swab into 
the bucket. The Medical Officer meanwhile lifts the contami­
nated syringe and lint and places tnem on the draL ning board 
(D.B. )• He then goes to the wash—nand basin (W.H.B.) and
washes his gloved hands thoroughly in running wafer using soap. 
Following this he soaks his hands in the baoin (A.) wnich
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contains 1:40 carbolic solution for a full minute. After 
drying his hands on the hand towel (H.T.), which he alone uses, 
he is ready to proceed with the next injection.
It was found in practice that if a few minutes were taken 
to explain to the patient the udos” and “don’ts” before his first
]
injection, no time was wasted and the patients co-operated well, j  
All injections ’were given with large bore hypodermic needles 
and the distance between the points of entry into the skin and 
into the vein was at least J inch. This achieved the important 
object of reducing the amount of leak from the venepuncture to a 1
I
minimum. Gare was taken to keep the rubber gloves and gown of ! 
the Medical Officer as free from contamination as possible and j 
the decontamination process was rigorously carried out. It will} 
be obvious that this technique of injection completely breaks the 
contact between one patient and the next. The gown and gloves 
of the Medical Officer were, of course, unsterile, the object of 
the technique being to break the contact between patients rather 
than to give injections under full aseptic conditions.
The method lends itself to team work and organisation and 
in practice with a well trained team and sound intravenous 
technique, 30 patients can be treated per hour, provided the 
sterilisation has been done previously and the “uncontaminated 
orderly” has a list of the drugs and doses which are to be given. 
While the Medical Officer is decontaminating his gloved hands the 
next injection to be given is being prepared. Each alternate 
group of five patients receiving their bismuth from a freshly 
boiled syringe, are given the injection by the “uncontarainated 
o r d e r l y who scrubs his hands in soap and water before and after
each injection
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The Results Obtained from the Investigation.
102 patients were treated using this technique and followed 
up for a period of 180 days or longer. Only one patient 
developed jaundice.
DISCUSSION.
Shortly before this technique was adopted I car ried out an 
evaluation of the relative merits of neoarsphenamine and 
mapharside. Alternate patients suffering from primary or 
secondary syphilis were given neoarsphenamine and mapharside, 
all the injections being given in my out-patient department. 
These patients were followed up for a minimum period of 15 
weeks after the first injection of arsenic and the incidence |
of jaundice occurring during these 15 weeks was as follows:- |
|
|
83 patients received mapharside; 42% developed jaundice.
71 patients received neoarsphenamine; 43% developed jaundic^
~  i
j
It was noted in cases in which the follow-up of these patient^i
was longer that the incidence still increased after the 15th j
I
week* It can therefore be concluded that the current j
l
incidence in the clinic was at least 42%.
During the year that this investigation was carried out there 
were 4 4 cases of jaundice admitted to my wards from the out­
patient department. All these cases had received injections
at other centres and 23 had received injections at my out­
patient department while incubating hepatitis. It is 
apparent therefore, that infectious cases were introduced 
into the clinic during the period of this investigation.
During this year 99 patients, who commenced treatment at my 
department and were subsequently transferred to other centres 
were followed up for 180 days. 24 of these cases developed
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hepatitis, the period between the last injection and the 
appearance of jaundice varying from 66 to 164 days. As the 
incubation period is usually about 60 to 70 days it is assumed! 
that these patients were infected after leaving my clinic.
A further 65 cases, commencing treatment at this centre and 
treated according to the special technique and later treated j 
at another centre using the same technique, remained free 
from jaundice for at least 180 days in all cases.
Laird (5) has investigated an out-break of post-arsphenamine 
jaundice at a centre where allneedles and syringes were 
sterilised by boiling but no organised method to prevent 
decontamination was in use. He concluded that the jaundice 
occurring during treatment was probably syringe transmitted 
and subsequent changes devised to eliminate all possibilities; 
of contamination resulted in the elimination of jaindice. 
Anwyl-Davies (29) has noted that in a clinic where the rate j 
of hepatitis following the administration of neoarsphenamine 
was more than 50%, that boiling syringes and needles between 
each injection did not reduce the incidence of jaundice.
I noted that in a civilian clinic in which I worked during 
the time of this investigation that the incidence of jaundice 
was less than 1% although syringes were not boiled between 
each injection. It may be concluded that until the ictero- 
genic substance is introduced into the clinic, no jaundice 
will occur even if the syringes are not boiled and 
contamination between patients occurs.
I have noted from records and personal observation that
(lie).
when jaundice occurs in a treatment centre that the incidence 
increases in a “snow-ball” manner unless precautions to 
prevent syringe transmission and other contamination are 
introduced.
In 1942 the routine treatment for primary and secondaiy 
syphilis was changed so that the total weight of neoarsphen­
amine was reduced. This measure fal led to arrest the steady 
rise in the incidence of post-arsphenamine jaundice.
,(111)
CONCLUSIONS.
%
It is concluded that:- 
Post-arsphenamine jaundice is an infective hepatitis 
indistinguishable from epidemic infective hepatitis and its 
spread amongst patients receiving arseno-therapy can be 
prevented by the introduction and operation of the use of a 
technique incorporating the principles described above.
The boiling of syringes and needles between each injection 
will not prevent the transfer of the icterogenic substance. 
Further precautions are necessary.
Infective hepatitis may occur in any clinic where numerous 
venepunctures are performed, provided that the infective agent 
is introduced and that the technique is such as to allow of 
the transmission of serum from one patient to another.
While transfer of an icterogenic substance between patients 
receiving intramuscular injections may occur, this is less 
likely than where venepuncture is being repeatedly performed.
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GROUP II.
II 1 W . H W M  i f a
INTRQDUCTION .
A group of major reactions to the trivalent arsenical drugs 
have been considered together because they probably have a common 
aetiology. As already stated, the management of exfoliative 
dermatitis has been different from that of the other reactions 
in this group, although its aetiology is probably similar. The 
reactions considered in this group are as follows
(a) The syndrome of Milianfs erythema of the 9th day.
(b) Haemorrhagic encephalopathy.
(c) Agranulocytosis. |
!
(d) Aplastic anaemia. I
(e) Arsenical purpura. • j
j
(f) Dermatitis (excluding exfoliative dermatitis). i
I
(g4 Exfoliative dermatitis. ' I
It has been recorded in the literature and noted in ray own 
practice that this group of reactions may follow the use of the 
trivalent arsenical drugs, the sulphonamides and to a lesser 
degree gold preparations and thiouracil; the common factor being 
the benzene ring present in all the above mentioned drugs. It 
is not sufficiently realised that all these reactions may follow 
the use of any one of the drugs and are clinically identical 
irrespective of the offending substance.
Thus Park and Platts (32) among others have described a 
syndrome which occurs characteristically some *7 — 10 days after 
the commencement of sulphonamide therapy. This syndrome is 
receiving increasing recognition and is similar to 9th day
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erythema (Milianfs syndrome) which may occur after the use of the j 
tri valent arsenical s. Sulphonamide thera py has "been complicated 
hy severe dermatitis (33, 34, 35 and 36), agranulocytosis (46). 
acute haemolytic anaemia (38), encephalopathy (37), and 
purpura (47). Again, following the use of gold therapy and 
thinuracil,agranulocytosis and dermatitis have "been reported (67).
The consensus of opinion is that all these reactions can 
only he explained on the hasis of allergy. With this hypothesis 
in mind Tate and Klorfajn (33, 34) have attempted the 
desensitisation of patients who have suffered from sulphonamide 
dermatitis, with success in some cases. In addition Park: (46) 
has desensitised a case of agranulocytosis arising from ^
sulphapyridine.
G-ruhzit and Dixon (39), Leifer, Ghargin and Hymen (40),
Levin and Keddie (41), Anwyl-Davies (29) and others have 
reported that mapharside in equivalent therapeutic doses is 
less toxic than the arsphenarnine group of drugs and causes 
fewer reactions. Cole and Palmer (42), Jordan and Traenkle(43), 
and Astrachan and Wise (44-) har e found that mapharside has been 
well tolerated in some cases in which toxic reactions to the 
arsphenamines have occurred.
Schooh, Alexander and Long (45) have reported on the results 
of desensitisation with mapharside after arsphenarnine dermatitis.
In view of the above, it was considered logical to attempt 
the desensitisation of patients exhibiting tue reactions in this j 
group, using mapharside. The commencing dose was a very small ! 
one (Q.OOlg.) and was increased subsequently, in the absence of j
fresh evidence of intolerance, to a therapeutic level.
(a) The Syndrome of Erythema of the 9th Day.
Milian first described this reaction to arsx-)henamine in 
1917. He termed it erythema of the 9th day and considered that 
it was due to a latent non-syphilitic infection stimulated bjr 
the administration of arsphenarnine.
In 1941 Peters (48) from a study of 54 cases at the Johns 
Hopkins Glinic pointed out that the reaction occurs between the 
5th and 9th days following the first injection of a trivalent 
arsenical. The rash is polymorphic, erythematous, 
scarlitiniform or macular and is accompanied by fever, malaise, 
headache, sore throat, nuchal rigidity, diarrhoea and enlargement 
of the superficial lymphatic glands. It occurs more frequently 
in women than in men and may be associated with nephritis, 
hepatitis or hepatomegaly without icterus, occurring just after 
the g>pearance of the rash. Peters showed that if treatment 
with the trivalent arsenicals was resumed within two weeks of 
the reaction 77% of patients developed a permanent intolerance 
to arsenic. If however treatment with the arsenicals was 
delayed for 1 - 2  months subsequent reactions were mild and 
occurred in only 28% of cases. The whole clinical syndrome is 
similar to that which occurs after the administration of the 
sulphonamides and, as with the sulphonamides, I have found that 
it is often associated with an eosinophilia*
The case-records and subsequent treatment of nine cases of 
this syndrome following the administration of neoarsphenamine
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and occurring in ray wards, are given below. All cases were 
males, and in none could a history of previous allergic states 
be elicited. „
For the sake of brevity and for consideration of space the 
records given below are brief and consist of positive findings 
only, except where negative findings are deemed to. be of 
importance.
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Case No. 1,
Male aged 30 years. Diagnosis: Secondary syphilis.
This patient was admitted to hospital with a chancre on his 
prepuce, moist lesions on the perineum and scrotum, condylomata 
lata around the anus and specific ulceration of both tonsils.
On admission, dark-ground examination of serum from his chancre 
and moist lesions was positive for T. pallidum and the ?/assermann 
Reaction was reported as strongly positive.
On. 24.9.44 he was given 0.45g. neoarsphenamine and 0 .2g. 
bismuth oxychloride. This was followed by 0.6g.neoarsphenamine 
and 0 .2g. bismuth oxychloride three days later and repeated after 
another five days.
On the tenth day after the first injection of neoarsphenamine 
an erythematous rash appeared on the trunk and limbs with macules 
on the extensor surfaces of the legs. The temperature rose to 
104 deg. F. .and sub a ded in forty eight hours. There was sane 
nuchal rigidity, the lymphatic glands in the neck and axillae 
were palpable and the glands in the groin slightly enlarged.
The epitrochlear glands were not palpable and there was no 
diarrhoea.
The .White blood count was 11,600 per c.mm.
Differential W.B.G:
Polymorphonuclear neutrophils 79%
Eosinophils ... 1%
Basophils 0%
large lymphocytes 3%
Small lymphocytes ••. 13%
Large mononuclears ... 4%
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The rash slowly faded, the skin returning to normal in four 
days. Two days later desensitisation using mapharside was
>mmeneed. A summary of treatment is given "below
24.9.44. 0.45g. neoarsphenamine. 0 .2g. hismuth oxychloride.
27.9.44. 0 .6g. neoarsphenamine. 0 . 2g. "bismuth oxychloride.
2.10.44. 0 .6g, neoarsphenamine. 0 .2g. "bismuth oxychloride.
4.10.44. Erythema of the 9th day.
8.10.44. Rash gone. Temperature normal.
10.10.44. O.OOlg. mapharside. 0 .2g. "bismuth oxychloride.
15.10.44. 0 .0 0 2g. mapharside.
14.10.44. 0.004g. mapharside.
16.10.44. O.Olg. mapharside. 0 .2g. "bismuth oxychloride.
17.10.44. 0 .0 2g. mapharside.
21.10.44. 0•04g. mapharsi de.
25.10.44. 0.06g. mapharside. 0 . 2g. "bismuth oxychloride.
Treatment with mapharside, O.OGg. "being given twice weekly, 
was co ntinued thereafter without further reaction.
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Case No. 2.
Male aged 22 years. Diagnosis: Primary syphilis.
The patient was admitted to hospital on 8.5.44. He had a
phimosis with a thick subpreputial discharge and bilateral 
inguinal adenitis. There was no urethral discharge and the 
urine contained no threads. A sore could he felt on the left 
side of the penis below the foreskin. On retracting the foreskin 
as far as possible, the edge of the sore could be seen.
Treponema pallidum was seen on dark-ground examination of serum 
from the sore. The Kahn Test was negative. Treatment was 
commenced on 21.4.44 with 0.45g. neoarsphenamine and 0.2g.bismuth 
osychloride. On 24.4.44 he was given 0.6g. neoarsphenamine and 
0.2g. bismuth oxychloride and on 28.4.44 he complained of sL ight 
headache and malaise.
On 29.4.44 an erythematous and macular rash appeared on the 
back, loins, the extensor surfaces of both wrists, over the right 
knee and on the dorsum of both feet. He complained of nausea, 
headache and slight sore throat. The temperature rose to 100.2 
deg. P. There was no nuchal rigidity or diarrhoea.
The white blood count was 12,200 per c.mm.
Differential white blood count:
Polymorphonuclear neutrophils 55%
Eosinophils • • • 5%
Basophils • • • 0%
Large lymphocytes • • • 6%
Small lymphocytes • • •
HCO
Large mononuclears • • •
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The serum bilirubin was less than 0.2mg. per 100 cc. The 
rash gradually faded and had disappeared "by 1.5.44. The 
temperature returned to normal on 30.4.44. The urine was normal 
throughout the reaction. Desensitisation was commenced on 
2.5.44 with O.Olmg. of mapharside. It was completed and 
treatment continued without further reaction. A summary of
treatment is given below:-
21.4.44. 0.45g. neoarsphenamine. 0 .2g. bismuth
24. 4.44. 0 .6g. neoarsphenamine. 0 .2g. bismuth
29.4.44. 9th day erythema. 0 . 2g. bismuth
2.5.44. O.Olg. mapharside.
3.5.44. 0 .0 2g. mapharside.
4.5.44. 0.04g. mapharside. 0 .2g. bismuth
6 .5.44. 0.06g. mapharside.
10.5.44. 0.06g. mapharside. 0 .2g. bismuth
13.5.44. 0.06g. mapharside.
Subsequently mapharside was given twice weekly without 
further reaction.
(1 2 0 )
Case No. 3.
Male aged 31 years. Diagnosis: Secondary syphilis.
This patient gave a history of gonorrhoea eight months before} 
admission to hospital. He v/as a case of secondary syphilis with
mucous lesions on the anterior surface of the scrotum, an injected!
|
but not ulcerated throat, a psoriasiform rash with generalised |
|i
adenitis and a healed chancre on the glans penis. Dark-ground 
examination of serum from a mucous lesion revealed Treponema j
pallidum and the Wassermann Reaction was reported as strongly ’! 
positive. j
Treatment was started on 18.10.44 when he was given 0.06g. I 
of mapharside and 0.2g. bismuth oxychloride. A further 0.06g. odd}: 
mapharside was given on the following day as this patient had be er 
placed on an intensive course of mapharside. No treatment was f
given on the following day but 0.06g. mapharside was given on i
each of the two subsequent days. j
On 24.10.44 the patient complained of headache and malaise. 
His temperature rose to 101 deg.P. There was slight nuchal {
rigidity and a macular rash over the trunk and limbs. The rash .
was most marked over the dorsum of the feet and the pyrexia 
continued for three days, varying between 99 deg.P. and 101.8 ■
deg.P. By the fourth day the temperature had returned to normal * 
and the rash was fading. During the acute stage of this reactianj 
there was vomiting and slight diarrhoea. The white blood count j1 
on 26.10.44, the second day of the reaction, was as follows:- j 
White blood count: 5,300 per c.mm. I
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Differential white blood count:
Polymorphonuclear neutrophils 65$
Eosinophils ... ... 1%
Basophils ... ... 3$
Large lymphocytes ... 7$
SrnaL.1 lymphocytes ... 24$
Large mononuclears ... 2$
This count was repeated on 29.10.44 with the following result:- 
White "blood count: 6,300 per c.mm.
Differential white "blood count:
Polymorphonuclear neutrophils 51$
Eosinophils ... ... 10%
Basophils ...
Large lymphocytes
Small lymphocytes ... 29$
Large mononuclears 
On 28.10.44. desensitisation was commenced and followed by 
intensive treatment without further reaction. A total of 1.5g. | 
of mapharside was given, A summary of treatment is given below:-
18.10.44. 0.06g. mapharside. 0 .2g. bismuth osychlori&e.
19.10.44. 0.6g. mapharside.
21.10.44. 0.6g. mapharside.
j ;
22.10.44. 0.6g. mapharside.
24.10.44. Erythema of the 9th day. 0.2g. bismuth oxychloride.;:
27.10.44. Hash fading. Temperature normal 0.2g.bi.oxychlor.
28.10.44. O.OOlg. mapharside.
ffi
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29.10.44. O.OOSg. mapharside.
30.10.44. 0.004g. mapharside.
31.10.44. O.Olg. mapharside. 0 .2g. bismuth oxychloride.
1.11.44. 0 .0 2g. mapharside.
2•11.44. 0.04g. mapharside.
3.11.44. 0.06g. mapharside.
5.11.44. 0.06g. mapharside. 0 .2g. bismuth oxychloride.
6.11.44. 0.06g. mapharside.
7.11.44. 0.06g. mapharside.
9.11.44. 0.06g. mapharside. 0 .2g. bismuth oxychloride.
Treatment was continued until a total of 1.5g. of mapharside 
had been given without further reaction.
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Case Mo. 4.
Male aged 29 years. Diagnosis: Primary syphilis.
This patient was admitted to hospital on 2 2 .1 1 .43 and 
diagnosed as sero-negative primary syphilis. He received 0.45g. 
neoarsphenamine and 0 .2g. "bismuth oxychloride on the day of 
admission. On 25.11.4-3 he was given 0.6g. neoarsphenamine and 
0 .2g. "bismuth osychloride. This was repeated on 29.11.43.
On 1.12.43 he presented a maculo-erythematous rash on the 
trunk: and limbs and complained of general malaise, sore throat, 
generalised aching and pains in all his large joints. His |
temperature rose to 100.4 deg.F. "but returned to normal in 48 hours 
The white "blood coun1* was performed on 2.12.43.
White "blood count: 4,800 per c.mm.
Differential white "blood count:
Polymorphonuclear neutrophils 62% 
Eosinophils ... ... 6%
Basophils. ... ... 0%
Large lymphocytes ' ... 6%
• Small lymphocytes ... 25%
Large mononuclears ... 0%
Transitional cells ... 1%
By 5.12.43 the rash had faded except for the macules v/hich, 
on the dorsum of the feet and insteps had "become petechial. 
There was no enlargement of the superficial lymphatic glands. 
All that remained of the rash on 10.12.43 was a few fading 
petechiae. On 11.12.43 desensitisation was commenced.
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Following desensitisation, mapharside was given in twice 
weekly doses of 0.06g. without further reaction. The patient 
complained of stiffness in the shoulders following the first 
two desensitising doses.
Treatment was as follows
22.11.4-3. 0.45g. neoarsphenamine. 0 .2g. ■bismuth
25.11.43. 0 .6g. neoarsphenamine. 0 . 2g. hi smuth
29.11.43 . 0 .6g. neoarsphenamine. 0 .2g. hisrauth
1 •1 2 .43. Erythema of the 9th day.
6.12.43. 0 .2g. "bismuth
11.12.43. O.Olg. mapharside.
13.12.43. 0 .2g. mapharside. 0 .2g. bismuth
17.12.43. 0.04g. mapharside.
20.12* 43. 0.04g. mapharside. 0 .2g. bisnuth
27.12.43. 0.04g. mapharside. 0 .2g. bismuth
3.1.44. 0.06g. mapharside. 0 . 2g. bismuth
9.1.44. 0.06g. mapharside. 0 .2g. bi smuth
Treatment was continued with O.OGg. mapharside twice weekly 
without further reaction.
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Case No. 5.
Male aged 29 years. Diagnosis: Secondary syphilis.
This man was admitted on 22.3.44 with secondary syphilis.
He exhibited peri-anal condylomata lata and marked ulceration of 
the soft palate and tonsils. Dark-ground examination of serum 
from the condylomata lata showed Treponema pallidum and the 
Wassermann Reaction was reported to be strongly positive. 
Treatment was commenced on 22.3.44 with 0.45g. neoarsphenamine 
and 0*2g. bismuth oxychloride. On 25.3.44 he was given 0.6g. 
neoarsphenamine and 0.2g. bismuth o^ychloride. This was
repeated on the morning of 30.3.44.
During the evening of 30.3.44 his temperature rose to 100.2 
deg.F. and an erythematous rash appeared on his fore-arms and 
thighs. This was accompanied by malaise and headache but no 
other symptoms. The pyrexia subsided in three days and the rash [
faded completely in six days.
White blood count: 8,600.
Differential white blood count:
Polymorphonuclear neutrophils 53%
Eosinophils ... ... 4%
Basophils ... ... 1%
Large lymphocytes ... 5%
Small lymphocytes ... 35%
Large mononuclears ... 2%
Desensitisation was commenced on 14.4.44 with O.OOlg. 
mapharside and followed by therapeutic doses of mapharside without 
further reaction.
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A summary of treatment is given below: -
22.5.44.
25.3.44. 
30.3.44*
5.4.44.
9.4.44.
14.4.44. 
15.4* 44.
16.4.44.
17.4.44.
18.4.44.
22.4.44. 
26 .4.44.
0.45g. neoarsphenamine. 
0 .6g. neoarsphenamine. 
0 .6g. neoarsphenamine. 
Erythema of the 9th day.
O.OOlg. mapharside. 
0 .00 2g. mapharside. 
0.005g. mapharside. 
O.Olg. mapharside. 
0 .0 2g. mapharside. 
0.04g. maphars ide. 
0.06g. mapharside.
0 .2g. bismuth osychloride. 
0 .2g. bisimith o^ychloride. 
0 .2g. bismuth o:xychloride.
0 .2g. bismuth osychloride. 
0 .2g. bismuth oxychloride.
0 .2g. bismuth o:xychloride.
0 .2g. bismuth oisychloride.
Treatment was continued with weekly injections of 0.06g. 
mapharside without further reaction.
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Case Ifo. 6 .
Male aged 28 years. Diagnosis; Primary syphilis.
This patient was admitted on 27.5.44 with sero-negative 
primaiy syphilis and commenced treatment on that day with 0.45g. 
neoarsphenamine and 0.2g. “bismuth oxychloride. On 50.5.44 he 
was given 0 .6g. neoarsphenamine and 0 .2g. bismuth oxychloride. 
This was repeated on 4.6.44 and 10.6.44. He exhibited no 
reaction until the 15th day of treatment following the fourth 
injection of neoarsphenamine when he complained of headache, 
malaise, and a sore throat with aching gums. He had a general­
ised adenitis but no fever and an erythematous rash on the backs 
of the hands and the dorsum of the feet which appe ared to be 
swollen, but did not pit on pressure. His symptoms disappeared 
in four days without treatment. Three weeks later arsenic was 
resumed with 0 .6g. of a different brand of neoarsphenamine; 
exactly the same symptoms recurred. A white blood count per­
formed at this time y/as as follows 
White blood count; 5,400.
Differential white blood count;
Polymorphonuclear neutrophils 55%
Eosinophils ... ... 14%
Basophils ... ... 1%
Large lymphocytes ... 10%
Small lymphocytes ... 15%
Large mononuclears ... 5%
Two months later the reaction occurred again after an
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injection of 0.45g. of a third "brand of neoarsphenamine. One 
month later on 23.9.44 desensitisation ?;as commenced with O.OOlg. 
mapharside. Following desensitisation therapeutic doses of 
mapharside were administered without reaction.
A summary of the treatment given is detailed below
2T .5.44. 0.45g. neoarg? henamine. 0.2g. "bismuth oxychloride
50 . 5 . 44. 0.6g. neoarsphenamine. 0. 2g. "bismuth oxychloride
4. 6.44. 0.6g. neoarsphenamine. 0.2g. "bismuth oxychloride.
10.6.44. 0.6g. neoarsphenamine. 
Erythema of the 9th day.
0.2g. "bismuth oxychloride.
17.6.44. 0.2g. "bismuth oxychloride.
24.6.44. - 0.2g. "bismuth oxychloride.
1.7.44. 0.6g. neoarsphenamine. 
Recurrence of erythema.
0.2g. "bismuth oxy chloride.
7.7.44. 0.2g. "bismuth oxychloride.
15.7.44. 0.2g. "bismuth oxychloride.
22.7.44. 0. 2g. "bismuth oxychloride.
26.8.44. 0.45g. neoarsphenamine. 
Recurrence of erythema.
0. 2g. "bismuth oxycliloride.
2.9.44. 0.2g. "bismuth oxychloride.
9.9.44. 0. 2g. "bismuth oxychloride.
16.9.44. 0.2g. "bismuth oxychloride.
23.9.44. O.OOlg. mapharside. 0.2g. "bismuth oxychloride.
30.9.44. 0.002g. mapharside. 0.2g. "bismuth oxychloride.
7.10.44. 0.004g. mapharside. 0. 2g. "bismuth oxychloride.
16.10.44. 0.004g. mapharside. 0. 2g. "bismuth oxychloride.
23.10.44. O.Olg. mapharside. 0. 2g. bismuth oxychloride.
6.11.44. 0.02g. mapharside.
(129)
14.11.44. 0.04g. mapharside.
20.11.44. 0.06g. mapharside.
Treatment was continued with 0.06g. mapharside weekly 
without further reaction.
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Case No. 7.
Male aged 20 years. Diagnosis: Primary syphilis.
This man was admitted to hospital with sero-positive primary 
syphilis. Treatment was commenced on 20.10.44 when he received 
0.45g. neoarsphenamine and 0.2g. bismuth oxychloride. Five days 
later he complained of malaise and a scarlitiniform rash appeared 
on the forearms and trunk with vesicle formation on the forearms. 
The temperature rose to 99,6 deg. F. and the superficial lymphatic 
glands in the neck and the epitrochlear glands now became 
palpable, the inguinal and axillary glands having been enlarged 
before treatment. There was some nuchal rigidity and diarrhoea. 
A trace of albumen appeared in the urine but this was transient, 
lasting only 24 hours and no casts were present. The pyrexia 
lasted for 24 hours only and a differential white blood count 
revealed no eosinophilia. The rash faded in six days.
Desensitisation was carried out using neoarsphenamine, 
without further reaction. The initial desensitising dose was 
0*01g. A summary of treatment is given below:-
0.45g. neoarsphenamine. 0.2g. bismuth oxychloride
0.2g.bisrauth oxychloride.
Erythema of the 9th day.
0.2g.bismuth oxychloride,
O.Olg. neoar^>henamine.
0.2g.bismuth oxychloride,
0.02g. neoarsphenamine.
O.lg. neoarg? henamine.
0.2g. neoarsphenemine. 0.2g.bismuth oxychloride
20.10.44.
23.10.44.
25.10.44.
27.10.44.
28.10.44.
29.10.44.
30.10.44.
1.11.44.
4.11.44.
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6.11.44. 0.3g. neoarsphenamine. 0.2g. bismuth oxychloride.
13.11.44. 0.45g. neoarsphenamine. 0.2g. bianuth oxychloride.
20.11.44. 0.6g. neoarsphenamine. Q.2g. bismuth oxychloride.
27.11.44. 0.6g. neoarsphenamine. 0.2g. bismuth oxychloride.
Weekly treatment with 0.6g. neoarsphenamine was continued 
without the recurrence of intolerance to the drug.
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Case No. 8.
Male aged 34 years. Diagnosis: Primary syphilis.
This patient was admitted to hospital on 8.2.44 with sero­
positive primary syphilis. On the day of admission to hospital 
he received 0.45g. neoarsphenamine and 0.2g. bismuth oxychloride. 
On 11.2.44. he was given 0.6g. neoarsphenamine and 0.2g. bismuth 
oxychloride.
On 15.2.44. he complained of mild headache and a sore throat, 
and the temperature was 99.2 deg.F. There was a' generalised 
enlargement of the superficial lymphatic glands, a maculo- 
erythematous rash on the arms and trunk and nuchal rigidity. The 
urine was normal. Examination of a blood film revealed no 
increase in the eosinophil white cells. On the following day 
the rash became vesicular on the forearms and spread to the lower 
limbs. Subsequently it faded and disappeared in six days.
Desensitisation was carriecjfout and treatment was completed 
without further reaction. A summary of treatment is given below
8.2.44. 0.45g. neoarsphenamine. 0.2g. bismuth oxychloride.
11.2.44. 0.6g. neoarsphenamine. 0.2g. bismuth oxychloride.
15.2.44. Erythema of the 9th day.
22.2.44. O.lg. ne oar ^henamine. 0.2g. bismuth oxychloride.
25.2.44. 0.2g. neoar^henamine.
28.4. 44. 0.4g. neoarsphenamine. 0.2g. bismuth oxychloride.
3.3 * 44. 0.6g. neoarsphenamine.
Treatment was subsequently completed without further 
reaction.
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Case No. 9.
Male aged 23 years. Diagnosis: Primary syphilis.
This case was admitted to hospital with sero-negative 
primary syphilis on 6.8.44. He commenced treatment on that day 
with 0.45g. neoarsphenamine and 0.2g. bismuth oxychloride. He 
received two further injections of 0.6g. neoarsphenamine and two 
of 0.2g. bismuth oxychloride on 9.8.44 and 13.8.44. On 15.8.44 
he complained of sore throat, stiffness of the neck and malaise. 
There was a macular rash on the face, trunk and limbs, nuchal 
rigidity, enlargement of the superficial lymph glands and the 
temperature rose to 104.2 deg.F. A differential white blood 
count showed an eosinophilia of 6%. Two days later he had 
diarrhoea and vomiting. The rash became purpuric on 19.8.44.
On 26.8.44 desensitisation was commenced with O.Olg. of 
mapharside. On 28.8.44 he was given 0.02g. of mapharside and 
this was followed by an erythematous rash of the trunk and limbs 
which lasted for 24 hours. On 1.9.44 a further attempt at 
desensitisation beginning with O.OOlg. of mapharside was made. 
This was successful and treatment v/as concluded without further 
reaction. A summary of treatment is given below:-
6.8.44. 0.45g. neoarg?henamine. 0.2g. bismuth oxychloride.
9.8.44. 0.6g. neoargphenamine. 0.2g. bismuth oxychloride.
13.8.44. 0.6g. neoarsphenamine. 0.2g. bismuth oxychloride.
15.8.44. Erythema of the 9th day.
21.8.44. 0.2g. bismuth oxychloride.
26.8.44. O.Olg. mapharside. 0.2g. bismuth oxychloride.
28.8.44. 0.02g. mapharside.
Recurrence of erythema.
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1.9.44. O.OOlg. mapharside.
2.9.44. 0.002g. mapharside. 0.2g. bismuth oxychloride.
4.9.44-. 0.004g. mapharside.
6.9.44. O.Olg. mapharside.
8.9. 44. 0.0 2g. mapharside. 0.2g. bismuth oxychloride.
10.9.44. 0 • 04g. maphar si de.
13.9.44. 0.06g. mapharside.
Treatment was subsequently continued without further
reaction.
To summarise:-
1. Nine cases of the syndrome of erythema of the 9th day are 
described together with the subsequent treatment given.
2. Five cases (Nos. 1, 5, 5, 6 and 9) were successfully I
desensitised when the first desensitising dose v/as O.OOlg. 
mapharside. |
3. Two cases (Nos. 2 and 4) were successfully desensitised j
starting with a dose of O.Olg. mapharside.
4. One case (No. 7) was desensitised commencing with O.Olg. of 
neoarsphenamine. |
j!
5. One case (No. 6) who experienced reactions to three different j!
|!
brands of neoarsphenamine was ultimately desensitised success- j
|
fully with mapharside, commencing with a dose of O.OOlg. j
6. One case (No. 9) reacted to an initial desensitising dose of 
O.Olg. of mapharside. Successful desensitisation was achieve*! 
when the initial dose was reduced to O.OOlg. of mapharside.
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(b) Haernorrhagi c Enc euhal opathv.
Haemorrhagic encephalopathy following the administration of 
the arsphenamines is a rarity. Moore (15) gives the figures for 
his own cases as 2 in 45,000 treated patients. Moore and Stokes 
(5) point out that this complication occurs more commonly in 
European peoples than in Americans, but note that reports in the 
American literature are becoming more numerous. Many cases of
haemorrhagic encephalopathy have been described recently in the
.
literature. (49, 50, 51, 52, 55 and 54). |
The condition often occurs early in the treatment of syphill^ 
usually after the first few injections of a trivalent arsenical |
compound. It will be noted that this corresponds in time with (
II
the occurrence of the syndrome of erythema of the 9th day. The i
condition usually becomes manifest 48 hours after the last |
f!
injection of the arsenical compound and is heralded by pyrexia | 
and headache, followed by deepening coma and delirium. j
Manifestations of the focal lesions in' the brain occur, including 
Jacksonian fits and there may be remissions and exacerbations ;| 
of these symptoms. Petechiae in the skin may occur and albumen | j  
and casts may be found in the urine. In about 75‘, of cases 
death occurs. Deep coma, loss of reflexes and hyperpyrexia 
characterise the terminal picture. The cerebrospinal fluid is I 
under pressure and its protein is increased; frequently there j; 
is no increase in the cells. At autopsy, generalised oedema 
of the brain is found with multiple punctate and ring 
haemorrhages most commonly seen in the basal ganglia.
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Subendocardial haemorrhages may "be present.
The recommended treatment includes sedation, lumbar puncture^ 
venesection and adrenaline every four hours, in large doses. 
Ransome and Paterson recommend that these cases be nursed in the 
sitting position. (52).
One case of haemorrhagic encephalopathy occurred in this 
group of toxic reactions and the case report and post-mortem 
findings were as follows.
Oase 1.
Male aged 39 years. Diagnosis: Secondary syphilis.
This patient was admitted to hospital on 9.6.43. He had
healed sores on the frenum and glans penis, a maculo-papular rash 
on the trunk and limbs, generalised enlargement of the superficial 
lymph glands, early anal condylomata lata and a mucous patch on 
the right side of the upper lip. There was a patch of varicose I 
eczema on the right leg at the site of an old, healed varicose j 
ulcer. Dark-field examination of serum from the condylomata ]
H
lata showed Treponema pallidum and the Wassermann Reaction was
I
strongly positive. f
On 10.6.43. he received 0.45g. neoarsphenamine and 0.2g. ]
bismuth oxychloride. The following day he complained of headache;' 
malaise and pain over the area of varicose eczema on the right 
leg. The temperature rose to 103.4 Deg.F. A diagnosis of |;
Herxheimer reaction was made and the patient confined to bed. \
{
The following day on 12.6.43 the temperature was normal and the j 
patient felt well. On 15.6.43 and on 22.6.43, 0.Sg.neoarsphen- j 
amine and 0.2g. bismuth oxychloride were given. On 23.6.44
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the patient complained of headache and slight nausea hub the 
temperature was normal. These symptoms had improved by 24.6.43. 
but pain recurred in the patch of varicose eczema. On the 
evening of 25.6.43 headache recurred. The patient was seen at 
07.30 hours on 26.6.43 when he had some clonic contractions of 
the lower jaw, rolling of the eyes and a bitten tongue. He was 
unconscious and was considered to be recovering from an epilepti­
form fit. The temperature was normal. His recovery was 
anticipated and he was given phenobarbiton gr.l intramuscularly. 
Ooma and slight clonic contractions of his jaw continued and a 
diagnosis of acute haemorrhagic encephalopathy was made. The 
pupils reacted normally to light and the reflexes were present. 
Adrenaline mlO was given intramuscularly and lumbar puncture 
performed. The fluid appeared to be under pressure, was clear 
and colourless and 20cc. were removed. Examination of the 
fluid revealed an increase in the protein content. Venesection 
was performed and 90cc. of blood were withdrawn. At 12.00 hours 
the patient was in a deep coma with stertorous breathing and had 
become incontinent of urine. The tendon end comeal reflexes 
were absent, the pupils were moderately dilated and did not react 
to light. Adrenaline mlO. was given intramuscularly. The 
temperature was 99.8 deg.F. the pulse 120 per minute and the 
blood pressure 130/80. By 18.00 hours the temperature had 
risen to 105 deg.F. A further 15cc. of cerebrospinal fluid 
were removed and lcc. of adrenaline given. This resulted in a 
slight improvement of the general condition hut was followed hy 
deepening coma and death at 01.40 hours on 27.S.43.
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Report „of the Post Mortem Examination carried out at 16.00 hours
on 18.6,43.
External Appearances.
This man appeared to he of normal height and build and of 
good nutrition. There was a red area on the under surface of 
the glans penis just to the right of the frenum about 5 m.m. in 
diameter with the appearance of a healed chancre. There were 
old brown scars scattered over the right tibia (about 1 c.m. in 
diameter) and some loss of external skin over the inner side 
of the right ankle. Posteriorly there was the mark of a recent 
lumbar puncture .
Internal Appearances.
Head and Brain.
There were about a dozen petechial patches on the dura mater
j
over the body of the sphenoid, just anterior to the sella turcicaj 
There was a diffuse congestion over the surface of both hemi­
spheres which was probably a post mortem phenomenon. There 
was no evidence of acute meningitis. No lesions of any kind 
were seen on careful naked-eye examination of the brain.
Neck and thorax.
There was seme congestion of the lower half of the trachea 
with numerous pin point petechiae in the mucosa, and some 
p u r p l i s h  congestion of the thyroid gland. The colloid content 
was normal. There was about 5 c.c. of clear fluid in the
pericardium. The heart weighed 10 oz. and was very dilated,
all chambers being affected. The valves were normal and the
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heart muscle cloudy, probably from autolysis. There were a 
group of subendocardial haemorrhages about the centre of the 
left surface of the interventricular septum. The left coronary 
artery was almost but not quite occluded by atheroma about 
li cm.from its origin. The remainder of this coronary artery 
and the right coronary artery,were normal.
Both lower lobes of the lungs were grossly oedematous and 
showed early bronchopneumonia with some areas of early softening. 
The smaller bronchi in this area v/ere filled with yellow pus. 
Abdomen.
The liver showed gross autolytic changes with many areas of 
foaminess. The pancreas, spleen and kidneys also showed auto­
lytic changes. All the other findings in a full post mortem 
examination were normal.
Conclusions.
The original lesion v/as the chancre on the glans penis, 
which was healed. There was no remaining evidence of secondary 
syphilis. The complete absence of any cerebral lesions evident 
to the naked eye was surprising in view of the history of 
encephalopathy following treatment with neoarsphenamine. The 
subendocardial haemorrhages were in keeping with death from a 
cerebral condition. The small petechiae in the sphenoidal 
dura mater were jresumably related to the encephalopathy. The 
coronary atheroma was of serious degree, but did not appear to 
have played any part in the fatal outcome.
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This v/as a typical example of acute arsenical encephalopathy 
terminating fatally. The symptoms referred to the site of 
previous varicose ulceration are of interest and may he of some 
significance in relation to the other cerebral manifestations of 
sensitisation. It is of interest to note the signs of vascular 
degeneration in this case. While no significant conclusion is 
justified it is difficult not to be impressed by this association 
of vascular degeneration and a rare vasculo-toxic reaction.
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(c) Agranulocytosis.
Although agranulocytosis is the most common example of blood 
dyscrasia complicating arsenotherapy, it is a rarity. The other 
"blood dyscrasias which occur are purpura and aplastic anaemia. 
These reactions occur most frequently after the use of sulphars- 
phenamine* Individual cases may present one or all of these 
blood dyscrasias and the mortality. rate is high. Moore (15) 
quoting from the publications of McCarthy, Wilson and Loveman gives 
the following figures
Dvscrasia. No. of cases. % Mortality Rate.
Haemorrhagic purpura 12 -
Haemorrhagic purpura and
agranulocytosis 7 14.2
i
Agranulocytosis 15 53.5
Aplastic anaemia 36 80.5
Agranulocytosis following the use of neoarsphenamine has been 
recently reported by various authors (75, 76, 77). The condition 
usually occurs early in treatment but may occur after many 
injections of the offending drug have been given.
In agranulocytosis the patient complains of sore throat, 
aching gums and general malaise with pyrexia. As the condition 
progresses sloughing, with inflammatory enlargement of the cervhal 
glands, appears on the pharynx and fauces including tonsils.
There is diminution or complete absence of the gismzLocytie 
elements of the blood and the patient is consequently highly
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susceptible to pyogenic infection.
One patient with agranulocytosis following the use of 
neoarsphenamine was studied and after desensitisation with 
mapharside his treatment was completed. A brief case report is 
given below.
Case 1.
Male aged 36. Diagnosis: Secondary syphilis.
This patient was admitted to hospital on 2.5.44 suffering 
from secondary syphilis having been exposed to infection about 
nine weeks previously. He had multiple chancres on the glans 
penis and prepuce, generalised adenitis, a maculo-roseolar rash 
on the trunk and mucous lesions in his mouth. Dark-ground 
examination of serum from the penile lesions showed Treponema 
pallidum and the Wassermann Reaction was strongly positive. 
Anti-syphilitic treatment with neoarsphenamine and bismuth 
oxychloride was commenced and between 2.5.44 and 7.S.44 he receive 
3.95g. of neoarsphenamine and 1.4g. of bismuth oxychloride. On
14.6.44 when he reported for treatment he complained of a sore
throat and general malaise. He appeared to have an acute
tonsillitis with injection of the fauces and had a temperature
of 99.8 deg.F. He was admitted to ny wards and given potassium
chlorate gargles and aspirin gr.10 four hourly. The urine was
nomal. On the following day the temperature rose to 104 deg.F.
he looked ill and a greyish slough was present on the left tonsiL
34 000 units of anti-diphtheritic serum were given, a throat swab 
* •
was taken and he was given sulpha thi a sole 4g. daily. On
16.6.44 the temperature had fallen to 99.2 deg.F. and the
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membrane had spread to "both tonsils, the anterior pillars of the 
fauces and along the gums behind the last two molar teeth. A 
blood count was performed.
Red blood corpuscles: 4,200,000.
Haemoglobin (Haldane): 86%'
White blood count: 6,500.
No granular cells were seen when a film of the blood 
was examined.
20ec. pentnucleotide were given intramuscularly and again 
eight hours later. The following day on 17.6.44 a further 40 cc. 
of pentnucleotide were given in two doses of 20cc. The white 
blood count was 5,500 per c.nim. and the blood film contained 5% 
myelocytes. On 18.6.44 a blood film contained 10% polymor­
phonuclear neutrophils and 6% myelocytes. The general condition 
of the patient appeared to be better and no further treatment 
was given. During the next two days the granular cells in 
the blood rose to 40% and the local condition in the mouth im­
proved greatly. An uninterrupted convalescence followed.
On 21.8.44 approximately one month after the occurrence of 
agranulocytosis, desensitisation using mapharside was carried out 
a close check being maintained on the blood picture. Mapharside 
was continued subsequently in twice weekly doses of 0.06g.until 
a total of l«8g. had been given without further reaction.
A summary of treatment is given below:- 
2 5 44 to
?!6!44. 4.05g. neoarsphenamine. 1.4g. bismuth oxychloride
14.6.44. Agranulocytosis.
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12.7.44 to
1.8.44. 0.3g
2.8.44. O.OOlg. mapharside. 0. 2g,
4.8.44. O.OOSg. mapharside.
5.8.44. 0.004g. mapharside. 0.2 g,
7.8.44. O.Olg. mapharside.
9.8.44. 0.02g. mapharside. 0.2g,
12.8.44. 0.04g. mapharsi. de.
16.3.44. 0.04g. mapharside. 0.2g,
19.3.44. 0.04g, mapharside.
22.8.44. 0.06g. mapharside. 0.2g,
Treatment was continued with 0.06g,
. "bismuth oxychloride,
. "bismuth oxychloride,
. "bismuth oxychloride,
. "bismuth oxychloride,
without further reaction.
During the period of this study no exanple of aplastic 
anaemia or arsenical purpura occurred.
Park (46) has shown that agranulocytosis follow, ng 
' sulphonamide therapy is a sensitisation reaction and has success 
fully achieved desensitisation. Falconer Epstein and Mills(68) 
have shown that agranulocytopaenic puspura follovang the use of 
neoarsphenamine is also a sensitisation phenomenon. From the 
above mentioned reports and the case herewith recorded it is 
concluded that agranulocytosis following arsenotherapy is a 
sensitisation phenomenon and that desensitisation of such 
cases can "be successfully effected.
(14-5)
(*3-) Arsenical Dermatitis -(excluding Exfoliative Dermatitis). 
Moore (15) gives the following table of incidence of the 
major post-arsphenamine skin reactions. The material is from 
that collected by the Go-operative Clinical Group.
Drug. No.of in.iections
Arsphenamine 105,942
Neoarsphenamine 30,779
Tryparsamide 19,964
Bimarsen 8,552
Sulpharsphenamine 7,912
S i lver arsphenamine 3,848
Mapharsen 56,290
per 1.000 injections. 
0.90 
0.31 
0.15 
0. S3 
1.39 
0.52 
0.053
In the present study of arsenical dermatitis this reaction 
was observed in 10 cases out of a group receiving 12,000 
injections of neoarsphenamine. This gives a rate of 0.83 per 
1,000 injections which is almost identical with the above quoted 
analysis.
Various theories of the cause of post-arsphenamine dermatitis 
have been postulated. It has been shown however, that many 
years after this complication has occurred, even minute doses of 
an arsphenamine will cause a recurrence of the dermatitis (15). 
This phenomenon can only be explained on a basis of allergy.
As has already been stated, exfoliative dermatitis has been
dealt with separately. The dermatological reactions which did
not go on to exfoliation have been divided into tv/o groups 
according to their presumed aetidogy. The first group consists
(146)
of the cases which exhibited a pure allergic reaction to 
neoarsphenamine and the second group is composed of individuals 
of the seborrhoeic type who had an exacerbation or initial attack 
of seborrhoeic dermatitis during their treatment with neoarsphen­
amine.
In the latter group six cases were investigated, three of 
whom had been treated for seborrhoeic dermatitis prior to 
receiving neoarsphenamine. The remaining three experienced 
their initial attack during their antisyphilitic treatment. In 
all these cases desensitisation was unsuccessful in spite of the 
use of mapharside and different proprietary brands of neoarsphen­
amine. ' In these cases, after a short rest and treatment of the 
seborrhoeic dermatitis,arsenic 'was tolerated for a few injections 
but in all cases sooner or later the dermatitis recurred. It 
is considered that the insertion of these case records would 
serve no useful function but for the sake of completeness the 
record of a typical case is given.
Case report.
Male aged 24 years. Diagnosis: Primary syphilis.
This patient was admitted to hospital with sero-positive 
primary syphilis on 30.4.43.
Treatment was commenced on 30.4.43. and the first course 
of treatment was completed without reaction although he had had 
an attack of seborrhoeic dermatitis two years previously.
During the rest period following the first course of treatment 
he had a mild seborrhoeic dermatitis of the back of the neck.
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This cleared up when treated with Lassar*s paste and the second 
course was commenced on 17.7.43. On 27.8.45. after the fifth 
injection of this course, he complained of an itchy rash on the 
hack of the neck and on the arms. On examination, this proved to 
he a recurrence of the seborrhoeic dermatitis. Neoarsphenamine 
was stopped and Lassarfs paste applied locaL ly. He had sane 
seborrhoea of the scalp. This was treated with 2fo sulphur and 
2% salicylic acid in a water soluble base. The injections of 
bismuth oxychloride were continued.
On 20.3.44, the patient*s skin being in a satisfactory 
condition, O.lg. neoarsphenamine was given. This resulted in a 
mild recurrence of the reaction and treatment was continued for 
three weeks with bismuth only. On 31.3.44, O.OOlg. mapharside 
was given without reaction. Attempted desensitisation was 
continued and by 14.4.44 the patient was receiving 0.06g. 
mapharside. Weekly injections of 0.06g. were tolerated for 
five weeks, when there was a recurrence of the dermatitis. 
Treatment was continued with bismuth only.
Two months later desensitisation with mapharside was again 
attempted and mapharside was given in therapeutic doses for five 
weeks after which the dermatitis recurred and treatment thereafter 
was with bismuth only.
Seven cases in which the aetiology was considered to be 
a sensitisation reaction to neoarsphenamine alone were studied 
and desensitisation was attempted and carried out successfully 
in six of these. The case records are given below.
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Case No. 1,
Male aged 29 years. Diagnosis: Primary syphilis.
This patient was admitted to hospital suffering from sero­
positive primary syphilis and treatment was commenced on 7.9.43 
with 0.45g. neoarsphenamine and 0.2g. "bismuth oxychloride. After 
five injections of neoarsphenamine a mild erythematous rash 
developed on the upper limbs on 15.10.43. This subsided without
treatment after arsenic was discontinued. On 13.12.43, 0.04g.
mapharside was given without reaction and, on 20.12.43, 0.06g. 
mapharside was given. This resulted in an acute itchy papulo­
vesicular rash on both arms and legs, principally on the flexor 
surfaces. This was treated with calamine lotion and Lassar*s 
paste and subsided completely in three weeks.
On 24.3.44, three months later, desensitisation was 
commenced with mapharside O.OOlg. and adequate treatment was 
eventually completed without further reaction.
A summary of treatment is as follows:-
7.9.43. 0.45g. neoarsphenamine. 0. 2g. bismuth oxychloride.
11.9.43. 0.6g. ne oar sphenamine. 0."2g. bismuth oxychloride.
18.9.43. 0.6g. neoarsphenamine. 0. 2g. bismuth oxychloride.
24.9.43. 0.6g. neoarsphenamine. 0.2g. bismuth oxychloride.
1.10.43. O.Sg. neoarsphenamine. 0.2g. bismuth oxychloride.
8.10.43. 0.6g. neoarsphenamine. 0. 2g. bismuth oxychloride
15.10.43. Dermatitis. 0.2g. bismuth oxychloride.
26.10.45. 0. 2g. bismuth oxychloride.
30.11.43 0.2g. bismuth oxychloride.
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6.12.43. 0. 2g. bismuth oxy chloride,
13.12.43. ■ 0•04g. Mapharside. 0.2g. hisrmith oxychloride,
20.12.43. O.Oog. Mapharside. 0 . 2g . bismuth oxychloride,
21.12.43. Recurrence of dermatitis.
27.12.43 to 25.2.44. 2.0g. bismuth oxy chloride,
24. o. 44. O.OOlg. Mapharside. 0. 2g. bismuth oxychloride
31.3.44. O.Olg. Mapharside. , 0. 2g. b i srauth oxychloride.
7.4.44. 0.02g. Mapharside. 0. 2g. bismuth oxychloride,
14.4*44. 0.04g. Mapharside. 0.2g. bismuth oxychloride,
21. 4.44 . 0.06g. Mapharside. 0.2g. bismuth oxychloride
23.4.44. 0.06g. Mapharside. 0. 2g. bismuth oxychloride
Treatment was continued without further reaction.
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Case No, 2.
Male aged 59 years. Diagnosis: Secondary syphilis.
When first seen this patient presented florid secondary j
syphilis with healed sores on the penis and scrotum, a wide-spread
[
papulo-squamous rash, generalised adenitis, condylomata lata !
i
around the anus and mucous lesions in the mouth. Treatment was j 
started on 28.4.44 and the first course of ten injections was I 
completed without reaction “by 24.6.44. After five injections of 
the second course, he complained of a slightly itchy papular rash 
on the legs and forearms. The administration of arsenic was 
stopped and the rash faded in three weeks. On 23.9.44 he was 
given 0.3g. of a different "brand of neoarsphenamine. This 
resulted in an acute recurrence of the dermatitis with an itchy 
papulo-erythematous rash on the arms, forearms, face and legs.
The rash subsided in three weeks with local treatment. On i
21.10.44 desensitisation using mapharside was commenced and j
treatment was subsequently completed without further reaction.
A summary of treatment is given below
28.4.44 to
24.6.44. 5.85g,, neoarsphenamine and 2.0g. bismuth oxychloride.
22.7.44. 0.45g., neoarsphenamine. 0.2g. bismuth oxychloride,
29.7.44. 0.6g. neoarsphenamine. 0. 2gi bismuth oxychloride,
5.8.44. 0.6g. neoar sphenamine. 0. 2g. bismuth oxychloride,
12.8.44. 0.6g. ne oar sphenamine. 0. 2g. bismuth oxychloride,
19.8.44. 0.6g. neo arsphenamine. 0.2g. bismuth oxychloride,
Dermatitis.
26.8.44. 0.2g. bismuth oxychloride
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0.9.44.
9.9.44.
16.9.44.
25.9.44.
21.10.44.
28.10.44.
4.11.44.
13.11.44.
18.11.44.
25.11.44.
1.12.44.
0.2g. "bismuth oxychloride. 
0.2g. "bismuth oxychloride. 
0.2g. "bismuth oxychloride.
0.5g. neoarsphenamine.
Recurrence of dermatitis.
O.OOlg. mapharside. 0.2g#bismuth oxychloride.
0.2g. bismuth oxychloride. 
0.2g. bismuth oxychloride. 
0.2g. bismuth oxychloride, 
0.2g. bismuth oxychloride. 
0.2g. bismuth oxychloride. 
0.2g. bismuth oxychloride.
0.002g. mapharside. 
0.004g. mapha.rside. 
O.Olg. mapharside. 
0*02g. mapharside. 
0.04g. mapharside. 
0.06g. mapharside.
Treatment was continued with mapharside without further 
reaction.
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Case No, 5.
Male aged 25 years. Diagnosis: Primary syphilis.
This patient was admitted to hospital with sero-positive 
primary syphilis. He commenced treatment for his infection on
16.1.44 and exhibited no reaction to treatment until after the 
21st injection of neoarsphenamine on 10.7.44. On 16.7.44 he 
developed a maculo-vesicular rash with an erythematous background 
on both forearms. He complained of itching over the area of the 
rash. Gal amine lotion was applied locally and the rash subsided 
and disappeared in eight days. On 7.8.44 desensitisation with 
O.OOlg. of mapharside was commenced and during and after 
desensitisation no further reaction to arsenic was experienced.
A summary of treatment is given below
16.1.44 to
13.5.44. 5.85g. ne o ar sphenamine. 2.0g. bismuth oxychloride.
10.4.44 to 
12.6.44. 5.85g. neoarsphenamine. 2. Og. bismuth oxychloride.
10.7.44. 0.45g. neo a r sphenamine. 0.2g. bismuth oxychloride.
16.7.44. Dermatitis.
17.7.44. 0.2g. bismuth oxychloride.
24.7.44. 0.2g. bi smuth oxychloride.
31.7.44. 0. 2g. bismuth oxychloride.
7.8.44. O.OOlg,. mapharside. 0.2g. bi smuth oxy chlori de.
14.8.44. 0.002g,. mapharside. 0. 2g. bismuth oxychloride.
21.8.44. 0.004g,. mapharside. 0. 2g. bismuth oxychloride.
28.8.44. O.Olg. mapharside. 0 . 2g. bismuth oxychloride.
4.9.44. 0 • 02g. mapharside. 0.2 g* bismuth oxychloride.
11.9.44. 0.04-g. mapharside. 0.2g. bismuth oxychloride.
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18.9.44. 0.04g. mapharside. 0.2g. bismuth oxychloride,
25.9.44. 0.6g. mapharside.
2.10.44. 0.6g. mapharside.
Treatment with 0.06g. mapharside was continued without 
further reaction.
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Oase No. 4.
Male aged 23 years. Diagnosis; Congenital syphilis.
This patient was admitted to hospital on 15.1.44 math 
balanitis and was diagnosed as congenital syphilis because of a 
repeatedly strongly positive Wassermann Reaction and the presence 
of stigmata. He commenced treatment for syphilis on 26.1.44 
with bismuth only and did not receive any injections of neoars­
phenamine until 15.3.44, 'when he m/as given an initial dose of
0.3g. of neoarsphenamine.
On 24.7.44 after 15 injections of neoarsphenamine he 
complained of an itchy rash on his arms. On examination there 
was a vesiculo-erythematous rash on both forearms, principally 
affecting the ante-cubital fossae and flexor surfaces of the 
forearms. Calamine lotion m/as applied locally and the injections 
of neoarsphenamine were discontinued. The rash disappeared 
in eleven days.
On 21.8.44 just less than one month after this reaction, 
desensitisation m/as commenced using O.OOlg. of mapharside. 
Desensitisation and treatment were completed without further 
reaction.
A summary of treatment is given below:-
26 1.44 to
8^3.44. 1.2g. bismuth oxychloride.
15.3.44 to
19.5.44. 4.2g. neoarsphenamine. 1.8g. bismuth oxychloride.
26.6.44. 0.45g. neoarsphenamine. 0.2g. bismuth oxychloride.
3.7.44. 0.45g. neoarsphenamine. 0.2g. bismuth oxychloride,
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10.7.44. 0.45g. neo ar sphenamine. 0.2g. 'bismuth oxychloride
17.7.44. 0.45g. neoarsphenamine. 0.2g. hismuth oxychloride
24.7.44. Dermatitis. 0.2g. bismuth oxychloride
51.7.44. 0.2g. bismuth oxychloride
7.8.44. 0.2g. bismuth oxychloride
14.8.44. 0.2g. bismuth oxychloride
21.8.44. O.OOlg. mapharside. 0.2g. bismuth oxychloride
28.8.44. 0.002g. mapharside. 0.2g. „ bismuth oxychloride
4.9.44. 0.005g. mapharside. 0.2g. bismuth oxychloride
11.9.44. O.Olg. mapharside.
18.9.44. 0.2g. mapharside.
25.9.44. 0.4g. mapharside.
2.10.44. 0.06g. mapharside.
Treatment was concluded using m^harside without further 
reaction.
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Case Ho. 5.
Male aged 36 years. Diagnosis; Secondary syphilis.
This patient was admitted with secondary syphilis. He had 
no evidence of a primary lesion "but had a pustular syphilide of 
the forearms and a faint generalised maculo-roseolar rash on the 
trunk. There was a generalised adenitis, healing mucous lesions 
in the mouth and condylomata lata around the anus. Treatment 
was commenced on 19.10.43, the first ten injections of neoarsphen-] 
amine being completed by 15.12,43 without any reaction.
On 18.2.44 after a further six injections of neoarsphenamine 
he developed a. typical, itchy, papulo-vesicular rash on the arms j 
and behind the knees. Arsenic was stopped and the rash involuted 
in 18 days with local treatment with calamine lotion.
On 2.5.44 desensitisation with mapharside v/as commenced 
and followed with therapeutic doses of mspharside without further 
reaction.
The treatment v/as as follows;-
19.10.43 to 
15.12.43. 5. 55g. neoarsphenamine. 0.2g. bismuth oxychloride
13.1.44. 0.45g. neoarsphenamine. 0.2g.bismuth oxychloride,
20.1.44. 0.6g. neoarsphenamine. 0.2g.bismuth oxychloride
27.1.44. 0.6g. neoarsphenamine. 0.2g.bismuth oxychloride
3.2.44. 0.6g. neoarsfhenamin'e. 0.2g.bismuth oxychloride
10.2.44. 0.6g. neoarsphenamine. 0.2g.bismuth oxychloride
17.2.44. 0.6g. neoarsp henamine. 0.2g.bismuth oxychloride
18.2.44. Dermatitis.
24.2.44. 0.2g.bismuth oxychloride
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3.3. 44. 0. 2g. hismuth oxychloride
10.3.44. 0.2g. hismuth oxychloride
17.3.44. 0. 2g. "bismuth oxychloride
21.4.44. 0.2g. "bismuth oxychloride
2.5*44. O.OOlg. mapharside. 0 . 2g. hismuth oxychloride
9.5 *44. 0.002g. mapharside. 0.2g. hisnuth oxychlori de
16.5.44* 0*004g. mapharside. 0.2g. hismuth oxychloride
23* 5.44. O.Olg. mapharside. 0 . 2g. hismuth oxychloride
30.5 * 44. 0.02g. . mapharside. 0.2 g. hismuth oxychloride
6.6.44. 0.04g. mapharside. 0. 2g. hismuth oxychlori de
13.6.44. 0.06g. mapharside. 0.2g. hismuth oxychloride
Treatment was continued with mapharside without further 
reaction.
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Case No. 6.
Male aged 4-2 years. Diagnosis: Syphilis (muco-cutaneous relaps^ ,
This patient had a muco-cutaneous relapse eighteen months 
after inadequate therapy, and was admitted to hospital for [
further treatment. He had previously received four injections of
arsenic and four of hismuth. He completed two full courses of j!
j|
neoarsphenamine and hismuth and twenty days after the last |
f!
injection of the second course (20th injection) on 29 .6.43, he j j  
complained of pain in his shoulders, knees and ankles. An itchy j 
maculo-papular rash v/as present over the knees and ankles together: 
with a few macules in hoth ante-cubital fossae. Jaundice |
i j
occurred on 17.7.43. Treatment was continued with hismuth only. | 
On 1.12.43. desensitisation was commenced with O.OOlg. j ;
mapharside and following this adequate treatment was completed 
without further reaction.
A summary of treatment is given helow:- 
8.1*43 to
10.3.43. 5.55g. neoarsphensmine. 2.0g. hismuth oxychloride.
7.4.43 to
9.6.43. 5.85g. neoarsphenamine. 2.0g. hismuth oxychloride.
29.6.43. Pain in joints and dermatitis.
17.7.4-3. Jaindice.
17.7.43 to
26.10.43. 2.4g* hismuth oxychloride.
.102.43. O.OOlg. mapharside. 0.2g. hismuth oxychloride.
5.12.43. 0.002g. mapharside. 0.2g. hismuth oxychloride.
12.12.43. 0.004g. mapharside. 0.2g. hismuth oxychloride.
17.12.43. O.Olg. mapharside. 0.2g. hismuth oxychloria.e.
(159)
24.12.43. 0.02g. mapharside. 0.2g. "bismuth oxychloride.
31.12.43. 0.04g. mapharside. 0.2g. "bismuth oxychloride.
7*1.44. 0.06g. mapharside. 0.2g. "bismuth oxychloride.
Treatment was continued and subsequently completed without 
further reaction.
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Case Ho. 7 has "been included here, "being one of interest, 
although desensitisation was not carried out*
Case Ho. 7.
t
Male aged 24 years. Diagnosis: Secondary syphilis.
Secondary syphilis was diagnosed on 16.12.42 and he 
developed a papulo-erythematous rash on the flexor surfaces of 
the arms and legs on 1.5.45 after one course (10 injections) of 
neoarsphenamine. On 10.5.43 he developed jaundice. Treatment 
was continued with bismuth only.
One year later on 8.3.44. neoarsphenamine was resumed in 
therapeutic doses without any attempt at desensitisation. Ho 
reaction resulted. The first dose given was 0.3g.neoarsphenamine 
the second 0.45g. neoarsphenamine and subsequent doses were 0.6g.
To summarise:-
1. 7 cases with cutaneous reactions to neoarsphenamine of a 
seborrhoeic type could not be desensitised with trivalent
arsenical drugs. v
2. 6 cases with cutaneous reactions to neoarsphenamine were 
desensitised using mapharside and commencing with an initial 
dose of O.OOlg. In all these cases adequate treatment v/as 
subsequently completed without further intolerance.
3. In one case neoarsphenamine was resumed in therapeutic doses 
one year after a cutaneous reaction without the occurrence 
of further signs of intolerance.
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(g) Exfoliative Dermatitis.
Exfoliative dermatitis following the use of the arsphenamines 
is a complication which may endanger life. As Stokes (5) has 
stated: !,This complication it will he recalled, ranks second only 
to haemorrhagic encephalitis as the most fatal of all unavoidable 
complications of a properly conducted arsphenaxnine therapy1*.
Moore (15) gives the incidence per 1,000 injections as ranging 
from 1,39 with sulpharsphenamine to 0.053 with mapharsen. He 
considers that exfoliative dermatitis is a sensitisation 
reaction and emphasises that subsequently, even a minute dose of 
a trivalent arsenical compound will provoke a generalised 
dermatitis. This statement implies that the reaction is allergic 
rather than toxic.
A new approach to the elucidation of this sensitisation 
phenomenon has resulted from a study of cellular metabolism. 
Peters (55) has pointed out that the carbohydrates, glucose and 
glycogen, are broken down in the cells to yarbon dioxide and 
water, each step being controlled by a definite enzyme and may 
involve phosphorylations. One of the later products of the 
process is pyruvic acid and the pyruvate oxidase system contains 
a component sensitive to very small quantities of arsenic. It 
follows that the metabolism of carbohydrate is poisoned at an 
important stage by traces of an arsenical. British anti­
lewisite (synonyms. B..&.L. and Ox. 217) (GH2SH.0HSi'i.0H20H) is a 
simple 1,2 dithiole and is capable of exerting a marked antidotal 
action against the poisoning of the pyruvate oxidase system by 
trivalent arsenicals and of reversing this poisoning when once
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established. These effects are brought about by the ability of 
the 1,2 dithiole to form stable ring compounds with the trivalent 
arsenical s. B.A.L. v/as made up in a 5% W/V solution in 10%
W/V benzyl benzoate in pea-nut oil and was administered 
intramuscularly. It was considered that B.A.L. administered 
to a case of exfoliative dermatitis might shorten the duration 
of the attack and reduce its severity. Two cases of exfoliative 
dermatitis following the administration of neoarsphenamine were 
treated with B.A.L.; a third received symptomatic • treatment only. 
Desensitisation v/as not attempted because of the known 
hypersensitivity of these cases and the potential danger to life. 
Brief clinical records of the cases with notes on their treatment 
are appended.
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Case No. 1,
Male aged 25 years. Diagnosis: Secondary syphilis.
This patient was admitted to hospital on 7.10.45 with a 
maculo-papular rash, a small penile sore and a generalised 
enlargement of the superficial lymphatic glands. Dark-ground 
examination revealed Treponema pa H i  dura and the Wassermann 
Reaction v/as positive.
Treatment was commenced on 8.10.43 and hetv/een this date and
7.12.43 he received 5.0g. neoarsphenanine and 2.4g. bismuth 
oxychloride. lie experienced no prodromal symptoms of dermatitis 
during this period.
On 23.12.43 he was re-admitted to hospital with exfoliative 
dermatitis of six days duration. On examination there was a 
generalised exfoliative dermatitis affecting the whole of the 
dermis. The skin at the flexures was cracked and there were 
cracks behind both ears. The scalp was scaling and there was 
a folliculitis of the back and shoulders, -blepharitis, con­
junctivitis and a small abscess at the outer can thus of the left 
eye. There was no pyrexia.
Treatment with calamine in oil to the skin and boric 
irrigations to the eyes v/as instituted.
On 26.12.43 the temperature was 99.0 deg.F. and the general 
condition was satisfactory. There was no change in the skin.
On 30.12.43 the abscess at the outer canthus of the left eye v/as 
incised and the cracks behind the ears had become grossly infected 
The condition of the skin improved during the next few days but 
the folliculitis on the back and shoulders became more marked
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and furuncles developed on the pubic region. On 7.1.44 the 
condition of the sic in was improved and there was much desquamation 
in all areas. On 9.1.44, 10.1.44 and 11.1.44 the patient 
received 2cc. B.A.L. intramuscularly twice daily, a total of 
12cc. in all.
By 14.1.44 the skin was greatly improved, although 
desquamation was still proceeding, but multiple abscesses 
of the neck, shoulders, pubic area, chest and limbs had 
developed. These were treated by incision and dressed with 
12.5% sodium sulphate compresses. On 18.1.44- the skin was 
free of all scaling except for the scalp and the soles of the 
feet. The texture of the skin was very good, being smooth and 
elastic. The superficial, abscesses increased in number and the 
residual sepsis lasted for a further two months.
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Gase No. 2.
Male aged 47 years. Diagnosis: Primary syphilis.
This patient was admitted to hospital on 9.11.43 suffering 
from sero-negative primary syphilis. Between 10.11.43 and
5.1.44 he received 5.85g. neoarsphenamine and 2g. bismuth 
oxychloride. On 12.11.43 he complained of an itchy rash on his 
wrists, forearms and thighs. A diagnosis of scabies was ma.de and 
he was treated with benzyl benzoate. Between 3.3.44 and 24.2.44 
he received 2.25g. neoarsphenamine and 0.8g. bismuth oxychloride 
without any reaction. On 25.2.44 he developed an itchy papulo- 
erythematous rash on both forearms. This was treated with 
calamine lotion but did not improve and on 14.3.44 he was 
re-admitted to hospital with exfoliative dermatitis. On 
admission there was marked scaling of the scalp and a generalised 
dusky pink erythematous rash with early exfoliation and weeping 
of the flexures. The hands and feet we re not involved at this 
time. The temperature was 100.4 deg.F. Galamine cream was 
applied to the skin and 2% sulphur and 2% salicylic acid in soft 
paraffin applied to the scalp. On the following day the 
temperature had fallen to 98.6 deg.F. The patient complained 
of sore throat and numbness of the hands. The skin remained 
unchanged but the fauces were injected and there was slight 
oedema of the dorsum of the hands. A differential white blood 
count showed an eosinophilia of 25.3% By lo.3*--4 the condition 
of the scalp had improved and there was less scaling present but
furuncles were developing in. both axillae and on the pubic 
region. There were also infected cracks behind both pinnae.
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On the following day, exfoliation had become generalised except j
for the hands and feet, and the patient1s temperature was j
99 deg. F. On ,18.3.44 treatment with B.A.L. was initiated and j
injections of 2 cc. were given intramuscularly tv/ice daily for 
the next five days until a total of 24 cc. had been given.
During this period abscesses developed in both axillae and the j
desquamation proceeded. Desquamation of the hands and feet did |
not occur until 28.3.44. On 30.3.44 the general condition |
was satisfactory and the sepsis in the axillae had almost 
resolved. On 12.4.44 there was slight scaling of the' scalp
. : i .
and flexures although the remainder of the skin was satisfactory, j
: j :
The skin at the flexures did not return to normal for many j
■I:
j;
months. I
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Gase No. 3.
Male aged 29 years. Diagnosis: Primary syphilis.
This patient v/as admitted to hospital on 6.4.44 suffering 
from sero-negative primary syphilis. Between 6.4.44and 1.6.44 
he received 5.85g. neoarsphenamine and 2.0g. bismuth oxychloride. 
Between 30.6.44 and 6.7.44 he received 1.05g. neoarsphenanine and
0.4g. bismuth oxychloride. He was re-admitted to hospital on
13.7.44 with dermatitis. On admission the temperature was 
99.8 deg. F. and the patient had a raised erythematous rash on 
the arms, legs, face end scaL p with some oedema of the face. 
Calamine lotion was applied locally. The pyrexia continued and 
the condition of the skin deteriorated. On 15.7.44 all areas 
of the skin were affected and there were weeping cracks at the 
flexures and behind the left pinna. The hair from the scalp, 
axillae and pubic area was shaved off and Lassar1s paste applied 
to all areas. Three days later there was exfoliation of the 
scaLp, face and limbs with large weeping areas on the neck, 
flexures and lower abdomen. On 2^7.44 there was some improve­
ment of the skin and exfoliation continued, while two furuncles 
had developed on the pubic area. Exfoliation of the hands and 
feet commenced on 26.7.44. By this time the weeping areas 
were improving and the furuncles on the pubic area were dis­
charging. Improvement continued steadily and by 15.8.44 
exfoliation had ceased, but there were still small weeping areas 
at the flexures. The skin had healed completed by 26.8.44.
(168)
To summarise:-
1. Three cases of exfoliative dermatitis are described. One case 
treated with B.A.L. showed marked improvement in the texture 
of the skin and in a second case treated similarly the results 
were inconclusive.
2. Secondary infection of the skin is a common and serious 
complication of exfoliative dermatitis. It is considered 
that the onset of this complication may be encouraged by the 
use of greasy or oily topical applications and a limited 
experience suggests that dry applications after shaving of 
the glabrous skin may be beneficial.
(169) ;
ta
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DISCUSSION. |
The management of the reactions to the trivalent arsenical j 
drugs in this group has "been conducted on the hypothesis that all’; 
these reactions are allergic in nature. In 1927 Frei (61) first j! 
demonstrated that arsphenamine dermatitis was the result of j
sensitivity rather than a direct toxic action. Falconer, !|
Epstein and Mills (68) have shown that purpura following the use |
I t
of a trivalent arsenical preparation is an allergic reaction. | 
Cases No. 5 and 6 of erythema of the 9th day and Cases No. 1 aid l 
2 of post-arsphenamine dermatitis In Section II, confirm the 
hypothesis. I
i-t
The work of Landsteiner and Jacobs (62) suggests that I
arsphenamine unites with a homologous serum or tissue protein to j  
form a hapten antigen. It is probable that the formation of j 
antigen is intradermal in origin. Shaffer (78) first suggested il 
that minute doses of arsenic might be deposited in the skin as ; 
the needle was being withdrawn after the intravenous injection 
of the arsphenamine s. Cormia (59) and others have reported the 
occurrence of postarsphenamine dermatitis following accidental, 
peri-venous injection of neoarsphenamine and it is generally 
accepted that the intra-dermal route offers the greatest prospects 
of success in experimental sensitisation.
It is considered that the trivalent arsenical drugs probably 
combine with a tissue or serum protein to form an antigen which 
stimulates the formation of antibody and that when the antigen 
and homologous antibody combine in sufficient quantity the 
sensitisation reactions become manifest. This may he
(170)
expressed crudely in the formula given below, the reaction 
obeying the mass law.
A. (antigen) + B. (antibody)— > c. (products of the reaction) 
It is only when the production and quantity of 0. rises above a 
threshold level that the state of sensitisation becomes manifest. 
It is considered that 0. is probably excreted slowly. Using 
this formula as a working hypothesis the process of desensitisa­
tion and the phenomena encountered can be explained satisfactorily
The process of desensitisation consists in adding a hapten 
antigen (A.) to combine with antibody (B.) at such a rate as to 
maintain the production of the products of the reaction (0.) 
belo?/ the threshold level required for the production of 
sensitisation reactions. Thus should the initial dose of A. 
cause a reaction by raising the production of C. above the 
threshold level, a smaller dose should, be given subsequently.
This is illustrated after erythema of the 9th day by Case No.9, 
and Cases 2, 4 and 7 demonstrate that if the amount of antibody 
produced by a particular individual is small, larger doses of
A. may be given with impunity. Cases 1 and 2 of post- 
arsphenamine dermatitis demonstrate that neoarsphenamine and 
mapharside have homologous specificity and when given intra­
venously act as haptens.
Gases of seborrhoeic dermatitis could not be desensitised 
and because of the potential danger to life no attempt was made 
to confirm the fact that this is also applicable to exfoliative 
dermatitis. Sulzberger and Rostenburg (79) have demonstrated 
the correctness of polyvalent sensitisation as applied to the
(171)
skin. It is probable that in seborrhoeie dermatitis and 
exfoliative dermatitis further trivalent arsenicals act as a 
complete antigens and not as haptens, increasL ng the formation 
of antibody and making de sensitisation impossible.
It is probable that antibody is slowly excreted. This 
would account for the fact that in case No. 7 of arsenical 
dermatitis, the administration of neoarsphenamine one year after 
the occurrence of dermatitis was not followed by further signs 
of intolerance.
This group of reactions is found after the use of several 
drugs, particularly those containing a benzene ring, and 
desensitisation as described above would probably be applicable 
in all cases.
(172)
CQNOLUSIONS.
It may be concluded that:- 
Following the administration of neoarsphenamine, erythema of 
the 9th day, agranulocytosis and arsenical dermatitis are 
allergic reactions.
Following erythema of the 9th day, agranulocytosis and 
dennatitis, short of exfoliation, due to neoarsphenamine, 
desensitisation can he carried out and further therapeutic 
doses of a trivalent arsenical given.
Desensitisation cannot he carried out in cases of dermatitis 
following neoarsphenamine where the reaction is of a 
seborrhoeic nature.
No definite conclusion concerning the use of B.A.L. in 
exfoliative dermatitis can he reached hut it is considered 
that further investigation may show that the preparation 
has a place in the treatment of this reaction to arsenotherapy
(173)
3TJMMAHT.
Introduction.
1. The objects of the study are given.
2. The material is described and the methods used in case 
talcing, examination and in laboratory procedures are given 
in detail.
Section I.
1. A clinical study and analysis of the signs and symptoms of
primary and secondary syphilis in a series of 250 cases is
described and photographs illustrating cases are included.
2. It is concluded that syphilis as studied in this series of
cases is a less virulent disease than that described as 
occurring in the 19th Oentury.
Section II.
1. A study of the reversal of the serological reactions of the 
blood in relation to treatment, with various schedules of 
trivalent arsenical compounds and with penicillin, in 9^9 
cases of primary or secondary syphilis is described.
2. It is concluded that:-
(a) Heoarsp henanine should be administered regularly, twice 
weekly, in adequate dosage to obtain satisfactory 
serological reversal.
Satisfactory results in the reversal of the serological 
reaction of the blood in cases of primary and secondary 
syphilis can be achieved with mapharside.
(c) A total dosage of 2,400,000 Oxford Units of penicillin 
is not adequate treatment for all cases of primary and
secondary syphilis. Further consideration of the 
optimum dosage end of the time/dcs age1 factor in 
such cases, is required.
Section III.
1. A study of the maoor reactions to the. trivalent arsenical
compounds and an investigation into new methods of management
of these reactions is described.
(a) An injection technique for the prevention of post- 
arsphenamine jaundice is described, the use of which 
reduced the incidence of the reaction from 42/S to less 
than 1%. The aetiology of post-arsphenamine jaundice
is discussed.
Cb) Nine cases of erjrbhema of the 9th day are described with 
their management by a process of desensitisation.
(c) One fatal case of haemorrhagic encephalopathy is 
described and the results of the post-mortem examination 
are given.
(d) One case of agranulocytosis following the administration 
of neoarsphenamine is described with subsequent 
arsenotherapy after desensitisation.
(e) A typical case of seborrhoeic dermatitis aggravated by 
the administration of the trivalent arsenical compounds 
is described with unsuccessful attempts at desensi­
tisation.
(f) Seven cases of dermatitis of an allergic type following 
the administration of neoarsphenamine are described with
successful desensitisation using mapharside.
(g)Three cases of generalised exfoliative dermatitis
following the administration of neoarsphenamine, two of 
which were treated with B.A. L., are described.
It is concluded that:-
(a) **Post-arsphenamine jaundice** is usually an infective 
hepatitis, indistinguishable from epidemic infective 
hepatitis an4its spread amongst patients receiving 
arseno-therapy can be prevented.
(b) Following the administration of the trivalent arsenical 
drugs, erythema of the 9th day, agranulocytosis and 
certain types of dermatitis are allergic phenomena and 
following desensitisation arsenotherqay- can be continued, 
The principles used can probably be applied to the whole 
group of drugs which cause these reactions.
(c) Desensitisation cannot be carried out in seborrhoeic 
individuals exhibiting dermatitis during treatment with 
the trivalent arsenical drugs.
(d) No definite conclusion concerning the use of 3.A.L. in 
the management of exfoliative dermatitis due to arsenic 
could be reached.
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